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Background and Purpose: Depression is increasingly prevalent as adults age, but is 
undertreated in older adults.  As populations in the US and the world are aging, it is 
important to evaluate the contributions of depression to cardiovascular risk factors, 
cognitive decline, and mortality.  The proposed study will examine avenues by which 
vascular depression is associated with cognitive decline, dementia, and all-cause 
mortality. First, we will examine the timing of the effect of vascular burden and 
cardiovascular risk factors (hypertension, hyperlipidemia, diabetes, ever smoking status, 
and overweight/obesity status) on onset of late-life depression. We will then determine 
whether depressive symptoms partially mediate the association of subclinical 
cardiovascular disease (CVD) with cognitive decline and dementia. Finally, we will 
evaluate the indirect effect of persistent depressive symptoms on the association between 
subclinical CVD and all-cause mortality.   
 
Methods: We investigated the effect of vascular burden and cardiovascular risk factors on 
the onset of late-life depression, using 1,190 former male medical students from the 
Johns Hopkins Precursors Study. Cox proportional hazards models using discrete time 
were used to evaluate the effect of vascular burden and cardiovascular risk factors 
occurring before and after age 65 on the onset of depression. Competing risks analysis, 
using the Long and Gray method, were used to account for the competing risk of 
mortality in later life. Also, we examined the role of persistent depressive symptoms as 
potential mediators in the associations of subclinical cardiovascular disease with onset of 
mild cognitive impairment (MCI) and dementia as well as all-cause mortality. To this, we 
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applied the counterfactual approach to causal mediation using time-to-event data from the 
Cardiovascular Health Study. Accelerated failure time models with Weibull distribution 
were used to examine the total, direct, and indirect effects of the association between 
subclinical CVD and MCI/dementia onset via persistent depressive symptoms, since the 
proportionality hazard assumption was not met. Cox proportional hazards models were 
used to evaluate total, direct, and indirect effects of subclinical cardiovascular disease on 
all-cause mortality via persistent depressive symptoms, since the proportionality hazard 
assumption was met. Both models were weighted by estimates of multivariable logistic 
regression models of persistent depressive symptoms on subclinical cardiovascular 
disease and baseline covariates.   
 
Results: Diabetes, hypertension, and hyperlipidemia before age 65 as well as vascular 
burden and diabetes after age 65 were associated with incident depression after age 65 
among participants who were depression-free up to age 65. Cardiovascular risk factors 
and vascular burden before age 65 were not associated with incident depression up at age 
65 with the exception of overweight/obese status having a protective effect against 
incident depression. Persistent depressive symptoms partially mediated the association 
between subclinical CVD with MCI/dementia onset, not all-cause mortality. Subclinical 
CVD was an independent risk factor of all-cause mortality. 
 
Conclusions: These results support the vascular depression hypothesis. Findings suggest 
that screening and treatment of depressive symptoms may reduce or delay the risk of 
incident MCI and dementia in older adults with subclinical CVD. Moreover, subclinical 
iv 
 
CVD was a strong predictor of all-cause mortality, independent of persistent depressive 
symptoms. Subclinical CVD and persistent depressive symptoms may lead to all-cause 
mortality on different pathways. Future directions involve the evaluation of domains of 
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The mechanisms underlying the relationship among cardiovascular disease 
(CVD), depression, dementia, and all-cause mortality are not well-understood (Almeida, 
Alfonso, Flicker, Hankey, & Norman, 2012; Barnes, Alexopoulos, Lopez, Williamson, & 
Yaffe, 2006; Barnes et al., 2012; Becker et al., 2009; Diniz, Butters, Albert, Dew, & 
Reynolds, 2013; Sheline et al., 2006). Mood disorders have been hypothesized as 
potential underlying mechanisms of associations of CVD with dementia and all-cause 
mortality, since depressive symptoms can often co-occur with CVD, and both are 
prevalent in older adults (Alexopoulos, 2010; Alexopoulos et al., 1997; Steffens, Helms, 
Krishnan, & Burke, 1999; Steffens, Krishnan, Crump, & Burke, 2002; Taylor, 
Aizenstein, & Alexopoulos, 2013). This notion is embodied in the vascular depression 
hypothesis: CVD leads to, maintains, or exacerbates depression in older adults 
(Alexopoulos et al., 1997). Common causes of depression and CVD are cardiovascular 
risk factors, which include diabetes, hypertension, hyperlipidemia, ever smoking status, 
and overweight/obese status.  
Depression, CVD, and cardiovascular risk factors are associated with greater risk 
and severity of cognitive decline and dementia (Barnes et al., 2006; Luchsinger et al., 
2005). People with three or more cardiovascular risk factors are more likely to have 
Alzheimer’s disease (AD) than those with less than three cardiovascular risk factors 
(Luchsinger et al., 2005). Depressive symptoms in later life (65 years and older) are 
associated with a two-fold increase in risk of developing AD and a three-fold increase in 
risk of developing dementia related to vascular disease (Luchsinger et al., 2005). Besides 
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its relationship with cognitive decline and dementia, depression is an independent risk 
factor for mortality in older adults (Schulz et al., 2000).  
Although studies have examined late-onset depression as underlying mechanisms 
of the association between CVD and dementia in older adults (Barnes et al., 2006; 
Sheline et al., 2006), we will examine whether modifiable cardiovascular risk factors 
throughout the life course could lead to depressive symptoms in older adults. Moreover, 
this study will elucidate vascular mechanisms leading to changes in cognitive function 
and mortality by evaluating the mediating role of depressive symptoms in CVD, 
cognition, and all-cause mortality.        
This study will use data from the Johns Hopkins Precursors Study, a prospective 
cohort of 1,337 former medical students for Specific Aim 1. For Specific Aims 2 and 3, 
data from the Cardiovascular Health Study (CHS), a geographically diverse prospective 
cohort study of 5,888 community-dwelling older men and women, will be used.  
 
Specific Aim 1: To compare the temporal associations between cardiovascular risk 
factors and incident depression before and after age 65.   
Hypothesis: There is a positive association of cardiovascular risk factors and vascular 
burden occurring before age 65 and onset of depression after age 65, not before age 65. 
  
Specific Aim 2: To determine whether persistent depressive symptoms partially mediate 
the association of subclinical cardiovascular disease with onset of mild cognitive 
impairment and dementia.   
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Hypothesis: Persistent depressive symptoms partially mediate the association of 
subclinical cardiovascular disease with the onset of mild cognitive impairment and 
dementia.   
 
Specific Aim 3:  To evaluate whether persistent depressive symptoms partially mediate 
the association between subclinical cardiovascular disease and all-cause mortality.   
Hypothesis: Persistent depressive symptoms partially mediate the association between 





 The following background section begins with an introduction to the 
epidemiology of depression in older adults and barriers to care for depression. Next, the 
vascular depression hypothesis is defined and discussed. The vascular depression 
hypothesis postulates that CVD leads to, maintains, or exacerbates depression in older 
adults. With these notions, we linked CVD and depression to two outcomes: onset of 
mild cognitive impairment and dementia as well as all-cause mortality. This section 
concludes with how cardiovascular disease and depression are associated with onset of 
mild cognitive impairment and dementia as well as all-cause mortality. 
  The topic of the first manuscript is to compare temporal associations of 
cardiovascular risk factors and incident depression before and after age 65. It is unclear if 
cardiovascular risk factors and vascular burden before age 65 lead to onset of incident 
depression before age 65. It is also unclear the degree to which cardiovascular risk factors 
and vascular burden before age 65 lead to an increased risk of the development of newly 
incident depression after age 65.  
 In the second manuscript, persistent depressive symptoms may partially mediate 
the association of subclinical CVD with onset of mild cognitive impairment and 
dementia. If there is an indirect effect of persistent depressive symptoms on the 
association of subclinical CVD with onset of mild cognitive impairment and dementia, 
then those at risk for developing clinical cardiovascular disease may delay onset of mild 
cognitive impairment and dementia by treatment and intervention on depressive 
symptoms. If there is no indirect effect, then subclinical cardiovascular disease and 
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persistent depressive symptoms may independently lead to onset of mild cognitive 
impairment and dementia.  
 In the third manuscript, we evaluated the indirect effect of persistent depressive 
symptoms on the association between subclinical CVD and all-cause mortality. If there is 
an indirect effect of persistent depressive symptoms on the association between 
subclinical CVD and all-cause mortality, then those with subclinical cardiovascular may 
decrease risk of death by intervening on depressive symptoms. If there is no indirect 
effect, then it is conceivable that both subclinical CVD and persistent depressive 







Epidemiology of late-life depression 
By 2050, there will be an estimated 83.7 million adults aged 65 and older in the 
United States, representing over 20 percent of the population (Ortman, Velkoff, & 
Hogan, 2014). Depressive symptoms are more common with advanced age, and the 
prevalence of depression doubles after age 80 (García-Peña et al., 2013). Among 
community-dwelling older adults, the prevalence of depressive symptoms in the past year 
is approximately 15% (Mulsant & Ganguli, 1999). The prevalence of both depressive 
symptoms and major depressive episodes rise to 20% and 12% respectively in primary 
care, 25% and 15% in acute care settings, and 40% and 16% in nursing home care 
settings (Mulsant & Ganguli, 1999). Depression is one of the leading causes of disability, 
and older adults are at elevated risk of both depression and dementia (Gonzalez, Tarraf, 
Whitfield, & Gallo, 2012).   
Presentation of depression differs between those aged 65 and older (later life) and 
those younger than 65. Those with depression in later life are more likely to have 
comorbidities, develop apathy, and show greater white matter hyperintensities as noted in 
MRIs, while those with depression before 65 years of age are more likely to have an 
increased genetic risk, psychiatric comorbidity, and cognitive vulnerability (Baldwin & 
O'Brien, 2002; McDermott & Ebmeier, 2009; Potter & Steffens, 2007; Schulz et al., 
2000; Steffens et al., 1999). Those with early-onset depression have shown impairment in 
episodic memory, whereas those with late-life depression have developed deficits in both 
executive function and processing speed (Alexopoulos et al., 2001; Ganguli, 2009; Jorm, 




Barriers to care for depression 
Depression is under-recognized and undertreated in older adults. A 2003 study of 
Medicare patients found that over 30% of those with depressive symptoms did not 
receive any treatment (Crystal, Sambamoorthi, Walkup, & Akincigil, 2003). 
Wittayanukorn, Qian, and Hansen (2014) found that, out of 1,177 individuals with 
clinically relevant depressive symptoms, approximately 70% did not receive any 
treatment and adults who were male, of Mexican American or African American 
ethnicity, and were 80 years or older were less likely to receive treatment. Additionally, a 
2012 survey of 1,318 people aged 65 years and older that was conducted by the John A. 
Hartford Foundation found that an estimated 46% of the respondents received treatment 
for depression, but they reported not receiving follow-up care after treatment initiation 
(Langston, Undem, & Callahan, 2012). Primary care practitioners who typically care for 
older patients can only identify about half of adult patients suffering from depression. 
Moreover, many primary care practices do not have a trained staff member for mental 
health issues. The combination of these two factors can lead to inadequate treatment and 
maintenance of antidepressant therapy. This lack of treatment and diagnosis of depression 
results in poorer outcomes (Mulsant & Ganguli, 1999). Besides failure of recognition and 
treatment of depression in the primary care setting, public awareness of the serious health 
risks related to depression in later life has been low. The 2012 survey also found that 
27% of the respondents believed that depression was part of the natural aging process, 
21% of the respondents knew that depression increased risk of the development of 
dementia, and 34% understood that heart disease and depression were associated 
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(Langston et al., 2012). Another reason why depression is undertreated is stigma, since 
depression was once thought to be the result of psychological weakness.   
 
Vascular depression hypothesis 
Individuals with late-life depression are at elevated risk of CVD (Baldwin & 
O'Brien, 2002). Many studies recognize CVD predicts the onset of late-life depression, 
which is also itself an independent risk factor for development of coronary artery disease, 
stroke, and diabetes, whereas vascular disease contributes to the development of 
depression, coronary artery disease, stroke, and vascular dementia (Baldwin & O'Brien, 
2002; Gorelick et al., 2011; Thomas, Kalaria, & O'Brien, 2004). The vascular depression 
hypothesis has been proposed to explain relationships between risk factors for 
cardiovascular disease and late-life depression (Alexopoulos, 2010; Alexopoulos et al., 
1997; Taylor, Aizenstein, & Alexopoulos, 2013). Cardiovascular diseases are thought to 
lead to, exacerbate, or continue depression in older adults (Alexopoulos et al., 1997). 
Further investigation of the vascular depression hypothesis will contribute to ways of 
delaying or preventing cognitive decline and increased disability as the population ages. 
 
Associations among subclinical cardiovascular disease, persistent depressive 
symptoms, mild cognitive impairment, and dementia   
We hypothesize persistent depressive symptoms partially mediate the association 
of subclinical CVD with onset of mild cognitive impairment and dementia. Depression is 
considered a risk factor of dementia (Wint, 2011). Findings from a meta-analysis suggest 
people with late-life depression are at elevated risk of all-cause dementia, specifically 
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vascular dementia (Diniz et al., 2013). There have been few studies examining the 
temporal interplay of vascular disease, depression, mild cognitive impairment, and 
dementia longitudinally (Barnes et al., 2006; Barnes et al., 2012; Sheline et al., 2006). In 
one study that followed 2,220 participants for seven years, those with depressive 
symptoms at study initiation had a higher risk of developing Mild Cognitive Impairment 
than those without depressive symptoms (Barnes et al., 2006). Sheline et al. (2006) found 
that those with late-life depression had slowed processing speed and executive 
dysfunction, which operate through fronto-striatal disconnection. Vascular burden, 
depression severity, age, and education were associated with slowed processing speed 
(Sheline et al., 2006). Subclinical CVD is a strong predictor of clinical CVD (Chaves et 
al., 2004; Kuller et al., 2006; Kuller et al., 1995), so subclinical CVD may be associated 
with persistent depressive symptoms and cognitive impairment. 
 
Associations among subclinical cardiovascular disease, depression, and mortality   
Besides examining associations among subclinical CVD, persistent depressive 
symptoms, mild cognitive impairment, and dementia, we will examine the indirect effect 
of persistent depressive symptoms on the association between subclinical CVD and all-
cause mortality. Severity of depression is a risk factor for all-cause mortality and 
cardiovascular-related mortality, and it is associated with cardiovascular risk factors 
(Ariyo et al., 2000; Schulz et al., 2000).  Another risk factor for all-cause mortality is 
subclinical CVD (Kuller et al., 2006).  
To our knowledge, only one study has examined whether depression plays a role 
in the association between CVD and all-cause mortality among community-dwelling 
10 
 
older adults. Almeida et al. (2012) examined whether depression modified the association 
between CVD and all-cause mortality. They reported that depression did not modify the 
association between CVD and all-cause mortality. Both depression and CVD each were 
independently associated with an elevated risk of death.  
 
Study population 
The target population is older adults living in the United States and countries 
similar to the United States who are at risk of developing cardiovascular disease and 
depression in the modern era. The source population is older adults living in the United 
States who are at risk of developing cardiovascular disease and depression in the modern 
era. The study population comes from the Johns Hopkins Precursors Study and the 
Cardiovascular Health Study. 
 
Johns Hopkins Precursors Study.  Caroline Bedell Thomas started the Johns Hopkins 
Precursors Study in 1947 by enrolling 1,337 students who matriculated into the 
graduating classes of 1948 to 1964 of The Johns Hopkins University School of Medicine. 
Participants have been followed regularly through annually mailed questionnaires since 
graduation, with an average response rate in over a five-year period of 90% (Gross et al., 
2011). Self-reports of cardiovascular parameters have been found to be accurate (Klag et 
al., 1993).    
 
Cardiovascular Health Study.  The Cardiovascular Health Study is a community-based 
study of 5,888 men and women aged 65 years and older at baseline. The primary 
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objective was to assess risk factors for the development and progression of cardiovascular 
disease in older adults, which arose out of a dearth of data on risk factors in older adults 
(Fried et al., 1991). Participants were recruited from Medicare eligibility lists in Forsyth 
County, North Carolina; Sacramento County, California; Washington County, Maryland; 
and Pittsburgh, Pennsylvania in 1989-1990. In 1992-1993, African American participants 
were actively recruited, and they comprise 15% of CHS participants. The eligibility 
criteria for both waves of enrollment were: 1) age 65 years or older; 2) not 
institutionalized; 3) expectation to stay in the current community for 3 or more years; 4) 
no active treatment for cancer; and 5) ability to provide informed consent without 
requiring a proxy respondent. Study visits occurred annually through 1998-1999 and 
telephone follow-up visits occur to present (Darsie et al., 2014). These study visits 
consisted of interviews, physical examinations, health questionnaires, and a fasting blood 
sample. Collection of hospital discharge summaries, and ICD-9 codes for all 
hospitalizations were collected during the follow-up period (Darsie et al., 2014). In 2005-
2006, 1,677 of the remaining cohort agreed to participate in an in-person visit to evaluate 
physical and cognitive functioning (Jenny et al., 2011). The in-person visit consisted of 
updated medical history, medication inventory, social history, self-reported health, 
physical function (measured through self-report, isometric grip strength, and gait speed), 
physical activity, cognitive assessments, and a fasting blood sample (Jenny et al., 2011). 
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Introduction:  Modifiable cardiovascular risk factors are associated with subsequent 
depression onset in older adults, but the effect of the timing of the cardiovascular risk 
factors occurring either before or after age 65 on incident depression is unclear.   
 
Method: Participants were 1,190 male medical students without a diagnosis of 
depression, who matriculated between 1948 and 1964 and were followed through 2011. 
Cox Proportional Hazards models were used to assess the associations of vascular 
burden, diabetes, hypertension, hyperlipidemia, smoking status, and overweight/obese 
status with onset of adjudicated diagnosis of incident depression. Models were adjusted 
by race, enrollment wave, baseline age, physical activity, and heavy alcohol use. 
 
Results: The analysis included 44,175 person-years of follow-up. Among participants 
who were depression-free up to age 65, vascular burden after age 65 (Hazard Ratio, 
[HR]: 2.13, 95% Confidence Interval, [CI]: 1.17, 3.90) was associated with onset of 
incident depression after age 65. The magnitude of vascular burden after age 65 is 
comparable to the effect of 8.2 additional years of age. Diabetes (HR: 2.79, 95% CI: 1.25, 
6.26), hypertension (HR: 2.72, 95% CI: 1.52, 4.88), and hyperlipidemia (HR: 1.88, 95% 
CI: 1.05, 3.35) before age 65 were associated with incident depression after age 65. Men 
diagnosed with diabetes after age 65 had 2.87 times the risk of developing incident 




Conclusions: Results support the vascular depression hypothesis. Depression screening 
in older adults with vascular burden may prevent and treat late-onset depression.  
 








Cardiovascular disease (CVD) is a common, growing public health challenge 
given increases in the older segments of the US population (Go et al., 2013). In 2013, 
83.6 million Americans had one or more CVD, of whom 42.2 million were 60 years of 
age or older (Go et al., 2013). Prior research suggests CVD and depression have a 
reciprocal relationship: each increases the risk of developing the other (Alexopoulos, 
2010; Alexopoulos et al., 1997; Barnes et al., 2012; Newberg, Davydow, & Lee, 2006). 
Despite being a top contributor to disability (García-Peña et al., 2013) and cognitive 
impairment (Diniz, Butters, Albert, Dew, & Reynolds, 2013), depression in older adults 
is often undertreated (Licht-Strunk, Beekman, de Haan, & van Marwijk, 2009).  
The vascular depression hypothesis has been used to explain how CVD 
promulgates late-onset depression (Alexopoulos et al., 1997). Cardinal features of late-
onset depression, here taken to indicate depression with incidence after age 65, are 
diagnosis of incident depression at age 65 and older and presence of vascular disease or 
cardiovascular risk factors (Alexopoulos et al., 1997). Secondary features include greater 
psychomotor disturbance, apathy, executive dysfunction, lesions in basal ganglia, and 
white matter hyperintensities (Thomas, Kalaria, & O'Brien, 2004). Modifiable 
cardiovascular risk factors include diabetes mellitus, hypertension, hyperlipidemia, 
obesity, and smoking (Barnes & Yaffe, 2011). The influence of cardiovascular risk 
factors on incident depression is likely more pronounced in older adults than in middle-
aged or younger adults, due to underlying physiological mechanisms (Taylor, Aizenstein, 
& Alexopoulos, 2013).   
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 Previous studies of associations of midlife cardiovascular risk factors and late-
onset depression have used cohorts with short durations of follow-up or follow-up 
without repeated measurement of midlife cardiovascular risk factors (Barnes et al., 2012; 
Sheline et al., 2006). The present investigation addresses these limitations by leveraging 
high-quality prospectively collected data on cardiovascular risk factors and depression 
from a long-standing cohort with extensive follow-up. The study is well-suited to 
examine cardiovascular risk factors occurring before vs. after age 65 and diagnosis of 
incident depression.   
We evaluated the timing during life of the occurrence of modifiable 
cardiovascular risk factors and determined the extent to which they are associated with 
subsequent development of incident depression. Pursuant to the vascular depression 
hypothesis, we hypothesized vascular burden and cardiovascular risk factors occurring 
before age 65 are associated with increased risk of developing incident depression after 
age 65, not before age 65. We examined this hypothesis using data up to age 65 to 
examine the association of cardiovascular risk factors with incident depression before age 
65. Among participants who survived depression-free up to age 65, we determined 
whether the presence of cardiovascular risk factors occurring before vs. after age 65 was 






The Johns Hopkins Precursors Study 
 
The Johns Hopkins Precursors Study, initiated in 1946, enrolled 1,337 medical 
school students in matriculating classes from 1948-1964 of The Johns Hopkins School of 
Medicine. Participants are followed approximately annually through mailed 
questionnaires to update morbidity and exposure information (Figure 2). The average 5-
year period response rate is 90% (range 87% to 94%). Vital status is known for over 99% 
of the cohort. Self-reports of body mass index (BMI) and systolic blood pressure (SBP) 
have been validated externally (Klag et al., 1993). Study procedures are reviewed 
regularly and approved by the Johns Hopkins University School of Medicine Institutional 
Review Board.  
We aimed to examine incident depression, hence excluded participants diagnosed 
with clinical depression before graduating from medical school (N=16), and those with 
no follow-up (N=9). The final sample size for this study was N=1,190 participants. 
 
Incident Depression  
 
The primary outcome was first diagnosis of depression. Participants or family 
members submitted approximately annually mailed questionnaires inquiring about 
medical and psychiatric conditions in a checklist (Chang, Ford, Mead, Cooper-Patrick, & 
Klag, 1997; Ford et al., 1998). Also, they answered questions about use of antidepressant 
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medication multiple times and lifetime history of receiving care from a mental health 
specialist for an emotional problem in 1988 (Chang et al., 1997; Ford et al., 1998). 
Depression before medical school graduation were ascertained by history and physical 
examination, review of student health records for information about treatment and 
hospitalization for depression, and exit interviews with specific questions about 
depressive symptoms. Those who committed suicide were included in the case definition 
of depression.  
Additionally, a committee of physician reviewers, unaware of the study’s 
hypothesis, adjudicated diagnoses alongside age of onset after reviewing participant self-
reports (Chang et al., 1997; Ford et al., 1998). Strict adherence to the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition was not possible, so the term, 
major depression, is not used. Questions about depression treatment assessed validity of 




 Vascular burden was defined by an adapted version of the Framingham CVD Risk 
Score (FCRS). FCRS is validated in participants aged 30-74 years without CVD, so we 
calculated scores within that age range (Cook et al., 2012; D'Agostino et al., 2008). The 
adapted version of the FCRS incorporates current smoking status, BMI, age, diabetes, 
and treated or untreated SBP (Cook et al., 2012). We used this version, since data for 
total and HDL cholesterol were unavailable for most visits. We assumed participants 
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diagnosed as hypertensive were treated for hypertension because diagnostic criteria for 
hypertension in the study included drug therapy (Wang et al., 2008). 
 
Cardiovascular Risk Factors 
 
 Cardiovascular risk factors were time-varying diabetes, hypertension, 
hyperlipidemia, overweight/obese status, and ever smoking status. Figure 2 provides the 
data collection schedule of these risk factors. Participants reported age and year of onset 
of diabetes, hypertension, and hyperlipidemia, which were confirmed by an adjudication 
committee. Overweight/obesity status was defined at each study interval by a cut-off of 
BMI≥25 kg/m2 (Barone et al., 2006). For ever-smoking status, participants were 





 All models were adjusted by white race, baseline age, enrollment cohort (1957-1964 vs. 
1948-1956), heavy alcohol use (daily/almost daily vs. less than daily) and physical 






We characterized the sample using means and percentages at baseline and age 65. 
Using Kaplan-Meier analysis, we compared the incidence of clinical depression 
developing at age 65 and older for time-invariant versions of each cardiovascular risk 
factor prior to age 65 (Kaplan & Meier, 1958). The difference in depression incidence 
between ever having and never having each cardiovascular risk factor before age 65 was 
tested using log-rank tests (Peto & Peto, 1972). This approach enabled us to assess 
whether the presence of cardiovascular risk factors before age 65 contributes to risk for 
incident depression after age 65. 
We compared the incidence of depression before and after age 65 using discrete-
time Cox proportional hazards survival models (Cox, 1972; Prentice & Gloeckler, 1978). 
We first modeled associations of time-varying indicators for vascular burden and 
cardiovascular risk factors occurring before age 65 with incident depression before age 
65 (dotted line in Figure 1). We did not anticipate strong associations, since the vascular 
depression hypothesis posits association of cardiovascular risk factors with depression 
onset in late life. We tested the proportional hazards assumption through log-log plots 
(Cox, 1972).  
Next, we modeled associations of time-varying indicators of vascular burden and 
cardiovascular risk factors occurring before and after age 65 with incident depression at 
age 65 or older using the subset that survived depression-free until age 65 (solid lines in 
Figure 1). In other models to tease apart the timing of the onset of vascular burden and 
each cardiovascular risk factor on risk for incident depression, we used a three-level time-
varying indicator for each cardiovascular risk factor: (1) newly occurred at age 65 or 
older, (2) newly occurred before age 65, and (3) never occurred as the reference group.  
27 
 
Hazard ratios and 95% confidence intervals for associations were estimated using 
discrete-time Cox proportional hazards models (Cox, 1972; Prentice & Gloeckler, 1978). 
Participants contributed time from age at graduation from medical school until age of 
incident depression, censoring due to loss to follow-up or death, or age of administrative 
censoring in 2011.  
FCRS was standardized to two standard deviations of the baseline distribution to 
place effect estimates on approximately the same scale as those for the binary CVD 
indicators (Gelman, 2008). To assist clinical interpretation, we divided the hazard for 
vascular burden by the coefficient for baseline age to estimate how much older a person 
would have to be at baseline to have the same magnitude of risk for incident depression. 
Statistical significance was defined by α<0.05. Analyses were conducted using STATA 
13.1 (StataCorp, 2013).  
 
Sensitivity Analysis  
 
To examine potential reverse causation, we calculated percentages of those who 
switched cardiovascular risk factor status from absence to presence and vice versa prior 
to one-year of incident depression. We excluded these participants with potential co-
occurring events to see if inferences changed. To evaluate the robustness of our findings 
for the selected age cutoff, we repeated the analysis using ages 70 and 75 instead of age 
65. To evaluate the potential for death being responsible for associations with 
cardiovascular risk factors instead of depression, we used competing-risks regression 
based on proportional sub-hazards model to examine the association of cardiovascular 
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risk factors with onset of death before incident depression (Fine & Gray, 1999). Despite 
small sample size, we repeated statistical analyses in women to evaluate robustness of 









Table 1 shows sample characteristics of 1,171 white and 19 non-white male 
participants at baseline (medical school graduation) and at age 65. Mean age at 
graduation from medical school was 26.3 years (standard deviation, [SD]=2.3 years). 
Fifty-two percent of the sample enrolled between 1948 and1956 (Table 1). Mean SBP 
rose from 116.0 mmHg (SD=9.3 mmHg) at baseline to 127.6 mmHg (SD=13.7 mmHg) at 
age 65. The number of cases of diabetes, hypertension, and hyperlipidemia increased 









) at age 65. There were 556 (50.9%) current 
smokers at baseline and 60 (9.9%) at age 65 (Table 1).  
There were 265 cases of incident depression (mean age of diagnosis = 57.1 years 
[SD=14.7 years]). The incidence of depression was 22.3% in the overall sample, 14.7% 
(n=175) before age 65 (N=1,190), and 11.0% (n=90) at age 65 and older (N=821). 
Among participants who died before age 65 (n=134, 11.3%), 28 (20.9%) had incident 
depression. Among participants who died after age 65 (n=321, 27.0%), 88 (27.4%) had 
incident depression.   
 




Using data up to age 65, participants contributed 38,825 person-years between 
baseline and onset of incident depression or age 65 (median 56 years). Table 2 shows 
unadjusted and adjusted hazard ratios for associations of vascular burden and 
cardiovascular risk factors with onset of incident depression up to age 65. After 
adjustment, vascular burden before age 65 was not associated with onset of incident 
depression up to age 65 (Hazard Ratio [HR]:0.84, 95% Confidence Interval [CI]: 0.59, 
1.21) (Table 2, top row). Overweight/obese men had 0.62 times the risk of depression 
before age 65 than men of normal BMI (95% CI: 0.42, 0.93). No other associations 
between cardiovascular risk factors and onset of incident depression up to age 65 were 
appreciably greater than null.   
 
Cardiovascular Risk Factors and Depression among Those Depression-Free to Age 65 
 
Figure 3 shows Kaplan-Meier survival curves comparing risk of incident 
depression diagnosed after age 65 between the group with a cardiovascular risk factor 
before age 65 vs. those who did not. Participants who survived depression-free up to age 
65 contributed 44,175 person-years between baseline and onset of incident depression, 
death, or end of follow-up in 2011.     
Table 3 shows adjusted hazard ratios for the associations of vascular burden and 
cardiovascular risk factors present before vs. after age 65 with onset of incident 
depression among those who never developed depression prior to age 65. Analyses were 
adjusted for baseline age, enrollment wave, physical activity at age 65 and alcohol use at 
age 65. Vascular burden level after age 65 (HR: 2.13, 95% CI: 1.17, 3.90) were 
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associated with onset of incident depression after age 65 (Table 3, top row). To provide 
context for this finding, we used the coefficient for baseline age in the hazards model to 
estimate how much older, on average, a person would be to have the same magnitude of 
elevated risk of incident depression for vascular burden. Among persons aged 65 and 
older, the elevated hazard of incident depression associated with a two SD higher 
vascular burden after age 65 is equivalent to being 8.2 years older. 
Men with diabetes diagnosed before age 65 had 2.79 times the risk of developing 
incident depression after age 65 than those without diabetes (95% CI: 1.25, 6.26) after 
adjustment (Table 3). The same was true of hypertension (HR: 2.72, 95% CI: 1.52, 4.88) 
and hyperlipidemia (HR: 1.88, 95% CI: 1.05, 3.35). Men diagnosed with diabetes after 
age 65 had 2.87 times the risk of developing incident depression after age 65 than men 
without diabetes (95% CI: 1.24, 6.62) after adjustment (Table 3). No other cardiovascular 
risk factor after age 65 was associated with onset of incident depression. 
 
Sensitivity Analysis  
 
Within one year of onset of incident depression (N=264, 22.5% of the sample), 3 
(1.1%) started or stopped smoking, 22 (8.3%) developed diabetes, 6 (2.3%) developed 
hyperlipidemia, 0 (0.0%) experienced an increase in BMI to 25 kg/m
2
 or greater, and 20 
(7.6%) developed hypertension. Inferences did not change after excluding these 
participants. 
The adjusted sub-hazard ratios of associations of cardiovascular risk factors with 
onset of death before incident depression in both subsets are shown in Table 4 and Table 
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5. Among the overall cohort, cardiovascular risk factors were not associated with death 
more than depression up to age 65 (p >0.05) (Table 4). Among the subset, diabetes before 
age 65 (Subhazard Ratio [SHR]=2.14, 95% CI: 1.17, 3.91) and ever smoking status after 
age 65 (SHR=2.23, 95% CI: 1.26, 3.91) were associated more with death than depression 
after age 65 (Table 5).   
Associations for women were in similar directions as those for men, although 
associations among women did not reach statistical significance (Table 6 & Table 7). 




In this longitudinal study of adults followed for up to 63 years after medical 
school, vascular burden and specifically, diabetes, hypertension, and hyperlipidemia were 
associated with increased risk of onset of incident depression among men who survived 
depression-free to age 65. Vascular burden accelerates onset of incident depression, since 
the magnitude of vascular burden after age 65 is comparable to the effect of 8.2 
additional years of age. Vascular burden and cardiovascular risk factors, except for 
overweight/obese status, were not associated with onset of incident depression 
developing before age 65. These findings are consistent with the premise of the vascular 
depression hypothesis that cardiovascular risk factors may underlie depression in adults 
over age 65 (Alexopoulos et al., 1997).  
Our study is broadly concurrent with past work distinguishing early-onset 
depression and late-onset depression pursuant to the vascular depression hypothesis 
(Bukh, Bock, Vinberg, Gether, & Kessing, 2011). There is substantial research 
suggesting greater roles medical and cardiovascular comorbidity in late-onset depression 
characterized as an initial depressive episode occurring later in life. Our study moves this 
research area by distinguishing between midlife and later-life cardiovascular risk factors. 
The vascular depression hypothesis implies accumulation of small-vessel disease 
could compromise the integrity of subcortical regions of the brain involved in mood 
regulation (Taylor et al., 2013). Modifiable cardiovascular risk factors are associated with 
small-vessel brain disease (Taylor et al., 2013). As vascular burden increases with 
increasing age, small-vessel brain disease could accumulate, thus elevating the risk of the 
onset of clinical depression in older adults. Taylor et al. (2013) proposed that pro-
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inflammatory processes contribute to acceleration of vascular damage and deficits in 
perfusion, resulting in white matter lesions that disrupt structural and functional 
connectivity. Pro-inflammatory states arise in aging and chronic disease via 
cardiovascular risk factors.  
Previous studies with shorter follow-up of one to two years have provided 
evidence in support of the vascular depression hypothesis, but none have examined these 
relationships throughout the life course as our study did (Lyness, King, Conwell, Cox, & 
Caine, 2000; Mast, Neufeld, MacNeill, & Lichtenberg, 2004). Unlike previous studies of 
one cardiovascular risk factor (e.g., diabetes (Mezuk, Eaton, Albrecht, & Golden, 2008), 
hypertension (Meyer, Armenian, Eaton, & Ford, 2004), hyperlipidemia (Chuang et al., 
2014), and smoking status (Pasco et al., 2008)), the present study examined vascular 
burden and cardiovascular risk factors. Epidemiologic studies with incident cases of 
depression are rare, and the long-term follow-up of a single cohort confers a considerable 
advantage by sharpening the focus on the temporal relationship between the 
cardiovascular risk factors and lifetime depression onset. 
We found an inverse association between overweight status and depression before 
age 65 among men. Evidence of an association between overweight status and depression 
has been mixed in other longitudinal studies (Palinkas, Wingard, & Barrett-Connor, 
1996; Roberts, Kaplan, Shema, & Strawbridge, 2000; Shelton & Miller, 2010). One 
potential biological mechanism is that carbohydrate cravings may temporarily relieve 
depressive symptoms via increased serotonergic activity (Lieberman, Wurtman, & Chew, 
1986). Further, we found a positive association between hyperlipidemia and depression 
onset after age 65, consistent with previous research (Chuang et al., 2014). 
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 Our study has considerable strengths. The Johns Hopkins Precursors Study is a 
prospective cohort study with lengthy follow-up, high response rates, and repeated 
measurement of cardiovascular risk factors (Chang et al., 1997; Ford et al., 1998; Wang 
et al., 2008). One strength is the sample consists of former medical students who became 
physicians, likely increasing the accuracy of self-reported conditions, and the same 
participants are followed prospectively (Chang et al., 1997; Ford et al., 1998; Wang et al., 
2008). Although the case definition for depression may have been more reliable if 
standard criteria were applied retrospectively, it would do so at the expense of validity if 
the presentation of depression changes with age. While new cases of depression 
identified in older age might be the most severe cases, if the participants reporting 
depression in later life were the most severe cases, then one would expect these 
participants would have reported depression earlier in life, not only in old age. Another 
advantage is the validity of self-reported cardiovascular risk factors compared to in-
person measures, thereby ensuring minimal bias (Klag et al., 1993). 
Several caveats of the study should be mentioned. Incidences of depression in our 
study are not comparable to nationally representative estimates because we excluded 
cases occurring before graduation, leading to lower incidence before age 65 than national 
estimates (Kessler & Wang, 2008). Additionally, physicians have higher rates of 
depression than the general population, thus the overall incidence rate in our sample of 
22.3% is slightly higher than national estimates of 16.6% (Kessler & Wang, 2008).  
Another caveat is other variables not incorporated into the analyses, i.e., genes 
and anxiety, could bias associations. We did not adjust models for mental status because 
medical school graduates are likely to perform at ceiling on screening tools developed to 
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detect dementias later in the life course. Selection factors could also affect our study’s 
generalizability; particularly, high socioeconomic status could have a protective effect 
against depression, thus leading to a potentially conservative estimate of risk related to 
depression (Ford et al., 1998). This limitation is also an advantage because the sample’s 
homogeneity and selectivity ensures fewer unknown confounders. A third limitation is 
the small sample size and limited number of cases especially in the under-65 analysis, 
resulting in wide confidence intervals. Fourth, some participants (11%) died before age 
65, thus death is a potentially competing outcome with depression after age 65 although 
sensitivity analyses showed no cardiovascular risk factors are associated with death prior 
to depression before age 65. A final limitation is that the sample and thus inferences are 
restricted to men. In a sensitivity analysis we repeated analyses in women; although 
associations were similar in magnitude, we were unable to conclude comparable 
relationships in women, due to limited sample size. 
 Depression is under-detected by primary care physicians (Licht-Strunk et al., 
2009), yet related to earlier risk of disability and cognitive impairment (Diniz et al., 2013; 
García-Peña et al., 2013). The predictive associations of modifiable cardiovascular risk 
factors and vascular burden with onset of incident depression are consistent with the 
vascular depression hypothesis, and underscore the need to screen older adults with 
multiple cardiovascular risk factors for depressive symptoms. Depressive care 
management can reduce depressive symptoms, increase quality of life, increase 
antidepressant treatment adherence, decrease hospitalizations, and extend life (Gallo et 
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Table 1. Comparison of male participants at baseline and age 65 from the Johns Hopkins 






Age at Graduation, mean (SD) 26.3 (2.3) --- 
Enrollment Wave   
     1948-1956  623 (52.4) --- 
     1957-1964 567 (47.7) --- 
Total Cholesterol, mean (SD), mg/dL 192.4 (29.2) --- 
Systolic Blood Pressure, mean (SD), mm Hg 116.0 (9.3) 127.6 (13.7) 
Diabetes, n (%) 6 (0.6) 50 (8.2) 
Hypertension, n (%) 28 (2.6) 253 (41.2) 
Hyperlipidemia, n (%) 94 (8.7) 251 (40.6) 
BMI, mean (SD), kg/m
2
 23.1 (2.6) 25.0 (3.4) 
Current Smoker, n (%) 556 (50.9) 60 (9.9) 
Lack of Physical Activity, n (%) 501 (50.5) 258 (32.7) 
Heavy Alcohol Use, n (%) 87 (8.3) 161 (19.2) 
Caucasian, n (%) 1,171 (98.4) --- 
 
P-values based on chi-squared tests and t-tests.  Tabulated values are means with standard 
deviations in parentheses, except where noted. mg/dL=milligrams per deciliter; mm 





Table 2.  Associations of vascular burden and cardiovascular risk factors with incident clinical depression before age 65 (N=1,190). 
Data from the Johns Hopkins Precursors Study (1947-2011). 
 
  Unadjusted  Adjusted
+
 











Vascular burden (FCRS) 0.83 (0.59, 1.15)  0.84 (0.59, 1.21) 
Diabetes  0.93 (0.34, 2.51)  1.00 (0.37, 2.73) 
Hypertension  1.06 (0.70, 1.61)  1.01 (0.64, 1.60) 
Hyperlipidemia 1.02 (0.68, 1.54)  0.80 (0.50, 1.27) 
Overweight or Obese Status** 0.78 (0.55, 1.11)  0.62* (0.42, 0.92) 
Ever Smoking Status 0.89 (0.65, 1.21)  0.87 (0.61, 1.23) 
      
 
*P<0.05 **Overweight or obese defined as 25kg/m
2
 or greater.  
+
Adjusted by race, baseline age, enrollment wave, baseline lack of 
physical activity, and baseline heavy alcohol use. FCRS = Framingham Cardiovascular Disease Risk Score 
 
This analysis refers to the dotted line in Figure 1. The hazard ratio associated with the FCRS represents a 2 standard deviat ion 




Table 3. Associations of vascular burden and cardiovascular risk factors with incident clinical depression after age 65 (N=821). Data 
from the Johns Hopkins Precursors Study (1947-2011).  
 
Cardiovascular Risk Factors 
Occurrence of 
cardiovascular risk 
factors before age 65 Vs. 
Never   
Occurrence of 
cardiovascular risk 
factors at age 65 and 











Vascular Burden (FCRS) 1.78 (0.22, 14.44) 
 
2.13* (1.17, 3.90) 
Diabetes 2.79* (1.25, 6.26)   2.87* (1.24, 6.62) 
Hypertension 2.72* (1.52, 4.88)   2.01 (0.87, 4.60) 
Hyperlipidemia 1.88* (1.05, 3.35)   1.48 (0.69, 3.19) 
Overweight or Obese Status** 1.33 (0.76, 2.33)   1.46  (0.42, 5.09) 
Ever Smoking Status 1.02 (0.26, 3.96)   1.35 (0.77, 2.38) 
 
*Statistically significant at P≤ 0.05. **Overweight or obese defined as 25kg/m
2
 or greater.  All analyses were adjusted by race, 
baseline age, enrollment wave, lack of physical activity at age 65, and heavy alcohol use at age 65.    
FCRS = Framingham Cardiovascular Disease Risk Score 
This analysis refers to the two solid lines in Figure 1.  The hazard ratio associated with the FCRS represents a 2 standard deviation 
difference in score.  The reference for individual conditions is never having the cardiovascular risk factor.  
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Table 4. Competing risk analysis using incident clinical depression as a competing risk 
for death and associations with cardiovascular risk factors after covariate adjustment 
(N=1,190). Data from the Johns Hopkins Precursors Study (1947-2011). 
 






Diabetes --- --- 
Hypertension 1.65 (0.34, 8.08) 
Hyperlipidemia 0.45 (0.07, 2.95) 
Overweight/Obese 2.97 (0.83, 10.61) 
Ever Smoking Status 2.46 (0.66, 9.19) 
 CI = Confidence Interval 
+
Adjusted by race, baseline age, enrollment wave, baseline physical activity, and baseline 
heavy alcohol use.  
 
Note: There were 28 participants who died, and 134 competing events of depression 




Table 5. Competing risk analysis using incident clinical depression as a competing risk of death and associations with cardiovascular 
risk factors after covariate adjustment (N=821). Data from the Johns Hopkins Precursors Study (1947-2011). 
 
 
Occurrence of Cardiovascular 
Risk Factor Before Age 65 Vs. 
Never  
Occurrence of Cardiovascular 
Risk Factor at Age 65 & Older 
Vs. Never 










Ratios 95% CI 
Diabetes 2.14* (1.17, 3.91)  1.61 (0.83, 3.14) 
Hypertension 1.33 (0.85, 2.08)  0.78 (0.45, 1.39) 
Hyperlipidemia 0.68 (0.42, 1.10)  0.69 (0.41, 1.17) 
Overweight/Obese 1.64* (1.03, 2.60)  1.15 (0.45, 2.90) 
Ever Smoking Status 0.98 (0.16, 6.16)  1.79* (1.15, 2.77) 
*P<0.05, CI = Confidence Interval 
+
Adjusted by race, baseline age, enrollment wave, physical activity at age 65, and heavy alcohol use at age 65 
 
 
Note: There were 145 individuals who died after age 65, and there were 38 competing events of depression before death.  
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Table 6.  Differences in the associations of vascular burden and cardiovascular risk factors with incident clinical depression before age 
65 between men (N=1,190) and women (N=118). Data from the Johns Hopkins Precursors Study (1947-2011). 
Cardiovascular Risk Factors 
Females   Males 
Unadjusted   Adjusted
+























Vascular burden (FCRS) 1.03 (0.33, 3.27) 
 
0.77 (0.19, 3.11) 
 
0.83 (0.59, 1.15) 
 
0.84 (0.59, 1.21) 




0.93 (0.34, 2.51) 
 
1.00 (0.37, 2.73) 
Hypertension 0.55 (0.07, 4.53) 
 
0.93 (0.10, 8.68) 
 
1.06 (0.70, 1.61) 
 
1.01 (0.64, 1.60) 




1.02 (0.68, 1.54) 
 
0.80 (0.50, 1.27) 




0.78 (0.55, 1.11) 
 
0.62* (0.42, 0.92) 
Ever Smoking Status 1.32 (0.48, 3.63) 
 
1.39 (0.43, 4.50) 
 
0.89 (0.65, 1.21) 
 
0.87 (0.61, 1.23) 
 
**Overweight or obese defined as 25kg/m
2
 or greater.  
+
Adjusted by race, baseline age, enrollment wave, baseline physical activity, 
and baseline heavy alcohol use. FCRS = Framingham Cardiovascular Disease Risk Score 
 
This analysis refers to the dotted line in Figure 1. The hazard ratio associated with the FCRS represents a 2 standard deviat ion 
difference in score.  The reference for individual conditions is never having the cardiovascular risk factor.  
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Table 7.  Differences in the associations of vascular burden and cardiovascular risk factors with incident clinical depression after age 
65 between men (N=821) and women (N=75). Data from the Johns Hopkins Precursors Study (1947-2011). 
Cardiovascular Risk Factors 
Females   Males 
Occurrence of 
cardiovascular risk 
factors before age 65 
Vs. Never   
Occurrence of 
cardiovascular risk 
factors at age 65 and 
older Vs. Never   
Occurrence of 
cardiovascular risk 
factors before age 65 
Vs. Never   
Occurrence of 
cardiovascular risk 
factors at age 65 and 





















Vascular Burden (FCRS score) --- ---   --- ---   1.78 (0.22, 14.44)   2.13* (1.17, 3.90) 
Diabetes --- ---   --- ---   2.79* (1.25, 6.26)   2.87* (1.24, 6.62) 
Hypertension 2.84 (0.15, 52.72)   2.45 (0.14, 43.35)   2.72* (1.52, 4.88)   2.01 (0.87, 4.60) 
Hyperlipidemia 3.47 (0.15, 78.74)   3.60  (0.19, 67.48)   1.88* (1.05, 3.35)   1.48 (0.69, 3.19) 
Overweight or Obese Status --- ---   --- ---   1.33 (0.76, 2.33)  1.46 (0.42, 5.09) 
Ever Smoking Status --- ---   0.87 (0.07, 10.54)   1.02 (0.26, 3.96)   1.35 (0.77, 2.38) 
 
*Statistically significant at P≤ 0.05. **Overweight or obese defined as 25kg/m
2
 or greater.  All analyses were adjusted by race, 
baseline age, enrollment wave, physical activity at age 65, and heavy alcohol use at age 65.   FCRS = Framingham Cardiovascular 
Disease Risk Score 
 
This analysis refers to the two solid lines in Figure 1.  The hazard ratio associated with the FCRS represents a 2 standard deviation 
difference in score.  The reference for individual conditions is never having the cardiovascular risk factor.  
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Table 8.  Differences in the associations of vascular burden and cardiovascular risk factors with incident clinical depression before 
ages 70 and 75 among men (N=1,190). Data from the Johns Hopkins Precursors Study (1947-2011). 
Cardiovascular Risk Factors 
Cutoff of Age 70   Cutoff of Age 75 
Unadjusted   Adjusted
+























Vascular burden (FCRS) 1.04 (0.78, 1.39)   1.04 (0.76, 1.43)   1.15 (0.88, 1.51)   1.11 (0.83, 1.50) 
Diabetes  1.62 (0.85, 3.09)   1.46 (0.71, 3.01)   1.88* (1.10, 3.20)   1.81 (0.99, 3.28) 
Hypertension  1.31 (0.92, 1.86)   1.25 (0.84, 1.84)   1.34 (0.97, 1.85)   1.24 (0.86, 1.78) 
Hyperlipidemia 1.04 (0.73, 1.49)   0.92 (0.61, 1.37)   1.10 (0.80, 1.53)   1.02 (0.71, 1.47) 
Overweight or Obese Status** 0.82 (0.59, 1.12)   0.67* (0.47, 0.95)   0.87 (0.65, 1.17)   0.75 (0.54, 1.05) 
Ever Smoking Status 0.99 (0.74, 1.31)   0.99 (0.72, 1.36)   1.03 (0.78, 1.35)   0.99 (0.73, 1.34) 
 
 
*P<0.05 **Overweight or obese defined as 25kg/m
2
 or greater.  
+
 Adjusted by race, baseline age, enrollment wave, physical activity at 
age 70 or age 75, and heavy alcohol use at age 70 or age 75. FCRS = Framingham Cardiovascular Disease Risk Score
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Table 9.  Differences in the associations of vascular burden and cardiovascular risk factors with incident clinical depression before and 
after ages 70 and 75 among men who survived depression-free to age 70 (N=733) or 75 (N=521). Data from the Johns Hopkins 
Precursors Study (1947-2011). 
  





















Vascular Burden (FCRS score) 3.81* (1.13, 12.87)   1.17 (0.46, 3.02)   --- ---   --- --- 
Diabetes 2.52 (0.97, 6.54)   2.59 (0.97, 6.89)   1.98 (0.68, 5.78)   1.57 (0.36, 6.82) 
Hypertension 2.15* (1.11, 4.15)   1.29  (0.46, 3.67)   3.63* (1.45, 9.10)   1.02  (0.20, 5.18) 
Hyperlipidemia 2.19* (1.10, 4.35)   2.74* (1.12, 6.71)   2.20 (0.97, 4.98)   1.44 (0.39, 5.25) 
Overweight or Obese Status 1.28 (0.67, 2.43)   1.05 (0.14, 8.06)   1.25 (0.58, 2.68)   --- --- 
Ever Smoking Status 1.78 (0.52, 6.08)   1.26 (0.65, 2.42)   0.83 (0.10, 6.62)   1.14 (0.53, 2.45) 
 
*P<0.05 **Overweight or obese defined as 25kg/m
2
 or greater.  
+
Adjusted by race, baseline age, enrollment wave, physical activity at 




Figure 1. Conceptual framework for the analysis Figures 
 
 
The dotted line illustrates the association of cardiovascular risk factors occurring before 
age 65 and the onset of incident depression up to age 65, using the full cohort. The solid 
lines show the association between cardiovascular risk factors occurring before age 65 or 
at and after age 65 and the onset of incident depression at and after age 65, using a subset 
of the cohort who survived up to age 65. Cardiovascular risk factors occurring after the 
onset of incident depression were excluded from the analysis. We used the cutoff of age 









Diagnoses for morbidities, cardiovascular disease, hypertension, and depression, were assessed approximately annually after 
graduation from medical school. Data about health behaviors (body mass index (BMI), blood pressure (BP) measurements) and habits 
(smoking status and frequency of alcohol consumption) were assessed at enrollment into the study around medical school graduation.  
These characteristics were assessed every five years from 1966-1984. After 1984, BMI and BP measurements were assessed in 1985, 
1988, 1993, 1998, 2001 (BMI only), 2002, 2003, and 2006. Hypertension was defined as self-reported blood pressure ≥160/95 mm Hg 
on one annual questionnaire, ≥140/90 mm Hg on ≥2 annual questionnaires, or as hypertension requiring drug therapy (Klag et al., 
2002; Wang et al., 2008). Participants self-reported multiple blood pressure readings varying from one to seven per questionnaire on 
approximately annual questionnaires, so an average of the SBPs was taken for each age of reported blood pressures. After 1984, habits 
were assessed in 1986, 1989, 1993, 1997, 2000, 2003, and 2006. Blood draw measures consisted of a complete blood panel with 
measures on total and HDL cholesterol. Total cholesterol was collected during medical school and in 2007-2008. HDL cholesterol was 




Figure 3. Kaplan-Meier plots of risk of incident clinical depression after age 65 by the presence of cardiovascular risk factors before 
age 65 (N=821).  
 
The x-axis is age in years, and y-axis is the depression-free survival probability. These plots use data from participants who were 
depression-free before age 65. 
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Introduction: Depression may underlie the association between cardiovascular disease 
and dementia, yet the causal mechanism is unclear. 
Methods: Causal mediation methodology was implemented to examine whether 
persistent depressive symptoms, defined as two consecutive scores ≥8 on the 10-item 
Center for Epidemiologic Studies-Depression Scale, partially mediated the association of 
baseline subclinical cardiovascular disease (CVD) with MCI/dementia onset in an 
analytic sample from the Cardiovascular Health Study (N=2,450). Excluded were those 
with baseline clinical CVD, MCI/dementia occurring before 5 years from baseline, and 
missing persistent depressive symptoms (n=3,438). Total effect was decomposed into 
direct and indirect effects (via persistent depressive symptoms), obtained from 
accelerated failure time model with weights derived from multivariable logistic 
regression of persistent depressive symptoms on subclinical CVD. Analyses were 
adjusted by age, race, sex, poverty status, marital status, and depressive symptoms at 
baseline. 
Results: Participants contributed 20,994 person-years of follow-up with a median follow-
up time of 9.4 years. Time to MCI/dementia is lower by a factor of 0.88 among those 
with subclinical CVD than those without subclinical CVD (95% Confidence Interval, 
[CI]: 0.83, 0.93). The total effect of subclinical CVD on MCI/dementia onset was 
decomposed into a direct effect (Time Ratio, [TR]=0.95, 95% CI: 0.92, 0.98) and indirect 
effect (TR=0.92, 95% CI: 0.88, 0.97). 64.5% of total effect was mediated via persistent 
depressive symptoms.  
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Conclusions: Persistent depressive symptoms partially mediate the association of 
subclinical CVD with MCI/dementia onset. Depression screenings among older adults 
with detectable vascular damage could be beneficial in reducing the risk of 
MCI/dementia. 
Key Terms: depressive symptoms, subclinical cardiovascular disease, mild cognitive 




 Cerebrovascular changes and depression are risk factors of cognitive decline and 
all-cause dementia (Alexopoulos et al., 2001; Jorm, 2010). Older adults with 
cardiovascular disease, such as coronary heart disease, may also have late-life depressive 
symptoms (Steffens, Krishnan, Crump, & Burke, 2002; Thomas, Kalaria, & O'Brien, 
2004). About 22% of community-dwelling older adults with depressive symptoms had 
coronary heart disease (Steffens et al., 2002). Those with late-life depressive symptoms 
have a two-fold increase in the risk of developing mild cognitive impairment (MCI) and 
dementia, compared to those without late-life depressive symptoms (Jorm, 2010; 
Snowden et al., 2015). Mood disorders may underlie the association between clinical 
CVD and cognitive decline (Alexopoulos et al., 1997), suggesting that mood disorders 
may partially mediate the association between CVD and cognitive decline.  
 Although clinical CVD and late-onset depression are associated with one another, 
the relative ordering of clinical CVD and late-onset depression is unclear. Studies have 
shown a longitudinal association between clinical CVD and onset of depression (Sheline 
et al., 2006) as well as depression and the onset of clinical CVD (Ariyo et al., 2000). 
Subclinical CVD is a strong predictor of future clinical CVD (Kuller et al., 2006), so 
subclinical CVD could be a surrogate for some vascular damage sustained to the vascular 
pathway. Once there is vascular damage, this may lead to the development of late-onset 
depression, resulting in a cascade towards dementia (Taylor, Aizenstein, & Alexopoulos, 
2013). 
In this study, we sought to elucidate how depressive symptoms may affect the 
association between subclinical CVD and the known neurodegenerative process with the 
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combination of MCI and dementia. To do this, we used the counterfactual approach to 
causal mediation using time-to-event data (Lange & Hansen, 2011). We examined the 
mediating role of persistent depressive symptoms on the association between subclinical 
CVD with MCI/dementia among those without clinical CVD. We hypothesized that 
persistent depressive symptoms partially mediate the association of subclinical CVD with 









There were 5,888 participants from the Cardiovascular Health Study (CHS), of 
which 3,602 participants agreed to undergo at least one brain magnetic resonance 
imaging (MRI) during the study. The CHS is a prospective cohort study of risk factors for 
coronary heart disease and stroke in adults 65 years and older. Participants are from four 
field centers located in Forsyth County, North Carolina; Washington County, Maryland; 
Sacramento County, California; and Pittsburgh (Allegheny County), Pennsylvania. The 
CHS design and recruitment strategy is described in more detail elsewhere (Fried et al., 
1991; Lopez, Jagust, DeKosky, & et al., 2003; Lopez, Jagust, Dulberg, & et al., 2003). 
We excluded those with baseline clinical CVD (N=783), prevalent dementia (N=145), 
those with MCI/dementia within five years of baseline (N=138), and those missing 
persistent depressive symptoms (N=86), resulting in 2,450 participants.  
 
Subclinical Cardiovascular Disease 
 
 The baseline examination included a detailed medical history, list of current 
medications, blood, blood pressure, electrocardiogram, ultrasonography of carotid 
arteries, and an echocardiogram in 1989-1990 (Chaves et al., 2004; Kuller et al., 2006).  
Subclinical cardiovascular disease was defined as having at least one of the following: (1) 
an ankle-arm-systolic blood pressure ratio≤0.9, (2) a percentage of stenosis of the internal 
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carotid artery (based on ultrasonographic findings) of more than 25%, (3) intimal medial 
thickness of the internal or common carotid artery higher than the 80th percentile of the 
CHS distribution, or (4) positive findings for angina or claudication on the Rose 
questionnaire without clinical history of angina or claudication (Chaves et al., 2004; 
Kuller et al., 2006). Methods for the development of the composite index of subclinical 
cardiovascular disease are described elsewhere (Kuller et al., 1994). 
 
Persistent Depressive Symptoms 
 
The 10-item Center for Epidemiologic Studies-Depression (mCES-D), a self-
reported measure of depressive symptoms experienced in the past week, was used to 
quantify clinically relevant depressive symptoms approximately annually (Andresen, 
Malmgren, Carter, & Patrick, 1994).  Its 10 items are coded on a scale of 0 to 3 points, 
for a maximum of 30 points, and focus on mood (5 items), level of irritability (1 item), 
energy level (2 items), concentration (1 item), and sleep (1 item). Higher score indicates 
greater depressive symptoms (Andresen et al., 1994). The reliability of the mCES-D 
(Cronbach α statistic, 0.80) is slightly lower than the original 20-item CES-D (Cronbach 
α statistic, 0.86), and there is a 0.88 correlation between the 10-item and 20-item versions 
of the CES-D (Kohout, Berkman, Evans, & Cornoni-Huntley, 1993). Persistent 
depressive symptoms were defined as having two consecutive mCES-D scores of 8 or 







Classification of Mild Cognitive Impairment and Dementia  
 
The classification of MCI and dementia was performed in two stages (Lopez, 
Jagust, DeKosky, et al., 2003). During the first stage, the sample was stratified into high 
and low risk of possible dementia among the living and dead participants, based on 
evaluation of cognitive testing, changes in cognitive scores, nursing home admission, 
vital status, and history of stroke. Among living participants, high risk of possible 
dementia was defined if participants had one of the following: 3MS score at one of the 
two most recent clinical visits, a 5-point decline in 3MS from MRI to last contact, a TICS 
score <28 and Informant Questionnaire for Cognitive Decline in the Elderly (IQCODE) 
score>3.6, history of incident stroke, history of dementia, or current residence in a 
nursing home. Medical records were not limited to hospitalizations (Lopez et al., 2003). 
Among dead participants, participants were classified at high risk of dementia if they had 
at least one of the following: 3MS<80 within two years of death, 5-point decrease in 3MS 
from MRI to year closest to death, and TICS score<28, IQCODE score>3.6 within two 
years of death, diagnosis of dementia, or history of incident stroke, or non-white. High-
risk whites and all African Americans (due to small sample size) were subjected to 
detailed evaluation of dementia diagnosis in three out of the four clinics (Lopez, Jagust, 




 Those classified as MCI and dementia cases were then reviewed by a dementia 
adjudication committee, which used standardized criteria for MCI and dementia 
diagnosis (Lopez, Jagust, DeKosky, et al., 2003). MCI and dementia were combined as 
an outcome, since both represent the same disease pathway leading to all-cause dementia 




Baseline covariates included age, race, male sex, poverty status, marital status, 
education level, ApoE ε4 status and depressive symptoms. Race was defined as either 
Caucasian vs. non-white. Poverty status was defined using the income cut-off of $11,770 
per Federal Poverty Level Guidelines (Dickon, 2015). Marital status was defined as either 
being married vs. unmarried. Education level was defined as either being a high school 
graduate or not. ApoE ε4 status was categorized as having at least one allele or not 
(Lopez, Jagust, Dulberg, et al., 2003). Depressive symptoms were baseline mCES-D 




We evaluated differences between those with and without baseline subclinical 
CVD at baseline, using t-tests for continuous variables and χ2 tests for categorical 
variables. Also, we examined the incidence and prevalence of MCI/dementia and 
64 
 
persistent depressive symptoms in the sample restricted to those having at least one MRI 
and not having baseline clinical CVD.  
 We estimated Kaplan-Meier survival curves to show differences in the cumulative 
incidence of MCI/dementia by presence and absence of subclinical CVD (Kaplan & 
Meier, 1958). A log-rank test was used to test the difference of the cumulative 
proportions of MCI/dementia onset between presence and absence of baseline subclinical 
CVD (Bland & Altman, 2004). Time from the first study visit, otherwise known as 
baseline, was the time-scale used in the analysis. Participants contributed time from 
baseline until MCI/dementia onset, loss to follow-up, or administrative censoring in 
1999.  
Figure 1 describes the framework for causal mediation to test whether the 
association of subclinical CVD with MCI/dementia onset was mediated by persistent 
depressive symptoms. Baseline subclinical CVD was the exposure of interest. Two-year 
lags were introduced in each pathway between exposure and mediator as well as mediator 
and outcome. Persistent depressive symptoms, the mediators, were measured 2-3 years 
after baseline (Figure 1). A multivariable logistic regression model was used to examine 
the association between exposure-mediator relationship. The outcome, time to 
MCI/dementia onset, was measured five years after baseline (Figure 1). We used a 
parametric accelerated failure time model (AFTM) using a Weibull distribution to 
determine the association between subclinical CVD and time to MCI/dementia onset, 
since the proportionality hazard assumption was not met. AFTMs are an alternative to 
Cox proportional hazards models when the proportionality hazard assumption is not met 
(Patel, Kay, & Rowell, 2006). 
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Mediation analysis was performed using the approach proposed by Lange & 
Hansen (2011) and VanderWeele (2011).  Let A be baseline subclinical cardiovascular 
disease, T time to MCI/dementia onset, M persistent depressive symptoms, and C a set 
of baseline covariates (Lange & Hansen, 2011; Rochon, du Bois, & Lange, 2014). 
Let Ta be the counterfactual event time if A had taken value a, Tam the counterfactual event 
time if A had taken value a and M had taken value m, and TaMa*  be the event time when the 
exposure is set to a, but the mediator is set to the value it would have had if the exposure 
had been set to a*. The total effect can be decomposed into natural direct and indirect 
effects in the following way: λTa(t) - λTa*(t) = [λTaMa(t) – λTaMa*(t)] + [λTaMa*(t)- λTa*Ma*(t)] 
(Grotta, 2012). Model assumptions include that (1) no unmeasured confounding of the 
exposure-outcome relationship, (2) no unmeasured confounding of the exposure-mediator 
relationship, (3) no unmeasured confounding of the mediator-outcome relationship, and 
(4) no unmeasured confounding of the mediator-outcome relationship after prior 
exposure (Lange & Hansen, 2011; Rochon et al., 2014).   
We estimated direct and indirect effects by modeling weighted AFTM with a 
Weibull distribution, using a duplicated dataset with two replications of the values of the 
exposure. This approach is similar to one used by Rochon et al. (2014) with the exception 
that we used AFTM, not a Cox Proportional Hazards model. In the first 
replication, A* was set to the original value of baseline subclinical CVD, whereas, in the 
second replication, A* was set to the opposite or “counterfactual” value of the subclinical 
CVD. Weights were determined by Wc=P(M|A*, C)/P(M|A, C). The proportions for the 
weights were estimated from a multivariable logistic regression model of persistent 
depressive symptoms on subclinical CVD and baseline covariates (Lange & Hansen, 
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2011; Rochon et al., 2014). Standard errors and 95% confidence intervals were 
determined by 5,000 bootstrap simulations. The weighted AFT model analysis was 
performed in R version 3.1.2 (R: A Language and Environment for Statistical Computing, 




 We conducted two sensitivity analyses. First, to test if we adequately adjusted by 
baseline covariates, we use propensity score matching, since the distribution of exposed 
and unexposed groups was unequal (Ridgeway, McCaffrey, Morral, Burgette, & Griffin, 
2014). We assessed the adequacy of matching by performing a series of diagnostic 
checks (Ho, Imai, King, & Stuart, 2007; Ridgeway et al., 2014). Propensity scores were 
assigned to each participant, based on estimates from a multivariable logistic regression 
using demographic characteristics, (i.e., age, sex, race, poverty status, marital status, 
education level), ApoE ε4 status, and baseline depressive symptoms. We conducted the 
main statistical analysis using the matched dataset. The analysis was further adjusted by 
baseline covariates to account for small differences in the matched sample (Ho et al., 
2007).  
Second, we examined incident dementia as a separate outcome and conducted the 
same analysis to determine whether inferences differed. Persistent depressive symptoms 








 Table 1 shows the sample characteristics for each model for the mediating effect 
of persistent depressive symptoms on the association between subclinical CVD and 
MCI/dementia onset. Those with baseline subclinical CVD were likely to be older, male, 
current smokers, and impoverished as well as have diabetes, treated hypertension, higher 
systolic blood pressure, lower HDL cholesterol, and shorter time on study, as compared 
to those without baseline subclinical CVD (all p’s<0.05) (Table 1). Also, those with 
baseline subclinical CVD were less likely to be high school graduates than those without 
baseline subclinical CVD (p<0.01) (Table 1). Those with and without baseline subclinical 
CVD were similar in terms of race, ethnicity, marital status, baseline depressive 
symptoms, ApoE ε4 status, antidepressant mediations, body mass index, and total 
cholesterol (all p’s>0.05) (Table 1).   
Table 2 shows the frequencies and percentages of the overall sample restricted to 
those without baseline clinical CVD. There were 1,677 (65.4%) participants who 
developed neither persistent depressive symptoms nor MCI/dementia, 159 (6.2%) who 
developed persistent depressive symptoms only, 592 (23.1%) who developed 
MCI/dementia only, and 137 (3.4%) who developed both persistent depressive symptoms 
(Table 2). Of those who developed both persistent depressive symptoms and 
MCI/dementia, 136 (99.3%) had persistent depressive symptoms prior to year 5 and 1 
(0.7%) had MCI/dementia onset before persistent depressive symptoms (Table 2).  
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 Figure 2 shows Kaplan-Meier survival curves comparing the risk of 
MCI/Dementia between those with and without baseline subclinical CVD. The 
cumulative proportion of MCI/dementia is higher among those with baseline subclinical 
CVD than those without baseline subclinical CVD (p<0.01). Participants contributed 
20,994.88 person-years to the study with mean follow-up time of 8.78 years 
(median=9.37 years).  
 
Mediating Effect of Persistent Depressive Symptoms on the Association of Subclinical 
CVD with MCI/Dementia Onset 
 
 The total effect of subclinical CVD on MCI/dementia onset and its decomposition 
into natural indirect and direct effects is shown in Table 3. The time ratio (TR) for total 
effect for the association between subclinical CVD and MCI/dementia onset was 0.88 
(95% Confidence Interval, [CI]: 0.83, 0.93). The time to MCI/dementia onset for those 
with baseline subclinical CVD is decreased by a factor of 0.83, as compared to those 
without baseline subclinical CVD (Table 3). The total effect was decomposed into a 
direct effect of subclinical CVD (TR=0.95, 95% CI: 0.92, 0.98) and indirect effect of 
persistent depressive symptoms (TR=0.92, 95% CI: 0.88, 0.97) (Table 3). The proportion 






 Results were similar when we used a matched sample based on propensity scores 
(Table 4). Figures 4 and 5 show diagnostic plots for propensity score matching. The time 
ratio for the total effect of subclinical CVD on MCI/dementia onset was 0.88 (95% CI: 
0.83, 0.93). Among those with similar baseline characteristics, the time to MCI/dementia 
onset for those with subclinical CVD decreased by a factor of 0.88, as compared to those 
without baseline subclinical CVD. The total effect was decomposed into the direct effect 
(TR=0.95, 95% CI: 0.83, 0.93) and the indirect effect (TR=0.92, 95% CI: 0.88, 0.97) 
(Table 4). 
 Additionally, we examined the indirect effect of persistent depressive symptoms 
on the association between subclinical CVD and onset of incident dementia. First, we 
evaluated survival curves from Kaplan-Meier plots to assess the association between 
subclinical CVD and incident dementia (Figure 3). The cumulative proportion of incident 
dementia is higher among those with baseline subclinical CVD than those without 
baseline subclinical CVD (p<0.01).  
Table 5 shows the decomposition of the total effect of subclinical CVD and 
incident dementia into the direct and indirect effects. The time ratio for the total effect of 
subclinical CVD on onset of incident dementia was 0.86 (95% CI: 0.73, 1.04) (Table 5). 
The time to onset of incident dementia for those with baseline subclinical CVD decreased 
by a factor of 0.86, as compared to those without baseline subclinical CVD. However, 
this estimate was not statistically significant. The total effect was decomposed into the 
direct effect (TR=0.87, 95% CI: 0.79, 0.96) and the indirect effect (TR=0.99, 95% CI: 
0.86, 1.16). Only the direct effect was significant (Table 5). Persistent depressive 
symptoms mediated 6.66% of the association between subclinical cardiovascular disease 
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and onset of incident dementia. Results were similar when we used a matched sample 





Persistent depressive symptoms partially mediated the association of subclinical 
CVD with MCI/dementia onset even after propensity score adjustment. Persistent 
depressive symptoms accounted for over half of the total association between subclinical 
CVD and MCI/dementia onset. These findings suggest that mood disorders may underlie 
the association between subclinical CVD and MCI/dementia onset. 
These findings are consistent with Jorm (2010) and Taylor et al. (2013) who noted 
that existing vascular disease could increase the risk of depression and vascular dementia. 
There are several mechanisms that could potentially explain the association among 
subclinical CVD, persistent depressive symptoms, and MCI/dementia onset (Taylor et al., 
2013). One potential mechanism is the occurrence of depression in older adults via 
hypometabolism of dorsal cortical regions and hypermetabolism of the ventral limbic 
structures (Alexopoulos, 2005). Neurobiological changes resulting from age, 
comorbidities, and stress may compromise frontolimbic structures. As severity of the 
neurobiological changes worsens, mood circuit functions are affected, thus potentially 
leading to depression and subsequent dementia (Alexopoulos, 2005). Another potential 
pathway underlying the association among CVD, depression, and MCI/dementia is that 
focal damage from white matter hyperintensities, common in people with cardiovascular 
risk factors and cardiovascular disease, can lead to deficits in neural circuitry 
(Alexopoulos, 2002).  
Another potential mechanism of the association among subclinical CVD, 
persistent depressive symptoms, and MCI/dementia is the inflammatory hypothesis 
(Taylor et al., 2013). Older adults may have proinflammatory states resulting from aging 
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and disease processes. Immune dysregulation may increase depression onset (Harrison et 
al., 2009) and contribute neurodegenerative process (Koyama et al., 2012; Rubio-Perez & 
Morillas-Ruiz, 2012).  
 Our study has several strengths. First, there was a large sample size of older adults 
with heterogeneity in demographic characteristics with up to 10 years of follow-up. 
Second, the CHS has a detailed evaluation of subclinical CVD and MCI/dementia. Third, 
the relative ordering of subclinical CVD, persistent depressive symptoms, and 
MCI/dementia onset was temporally intact for the mediation analysis, since persistent 
depressive symptoms occurred before MCI/dementia onset among those who had both 
persistent depressive symptoms and MCI/dementia. Also, there was minimal (3%) 
missingness for persistent depressive symptoms. All participants had measures on 
subclinical CVD and MCI/dementia onset. 
 There are several limitations. First, a main assumption of the mediation analysis is 
that all relevant confounders are included in the analysis. We included all potential 
baseline confounders, such as baseline demographic characteristics, baseline depressive 
symptoms, and ApoE ε4 status. Moreover, when we used AFTM with the matched 
dataset based on propensity scores, we obtained similar results. Another limitation is the 
requirement of no other variables that confound the mediator-outcome association, but 
this is untestable in observational studies (Lange & Hansen, 2011). Besides these 
limitations, there was no indirect effect of persistent depressive symptoms on the 
association between subclinical CVD and onset of incident dementia. Incident dementia 
represents a more severe neurodegenerative process. Also, there could have been a 
limited number of cases to find an indirect effect.   
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Persistent depressive symptoms may underlie the association between vascular 
processes and MCI/dementia onset. Older adults who have experienced a cardiovascular 
event are prone to subsequent depression and dementia. Screening for depressive 
symptoms prior to a diagnosis of clinical CVD may delay or reduce the incident 
MCI/dementia cases in older adults, especially among older adults with some evidence of 
vascular damage. A future direction of this study is to examine the indirect effects of the 
different domains of the mCES-D, i.e., somatic complaints, interpersonal conflicts, 
depressed affect, and positive affect, on the association of early vascular damage and 
cognitive decline. We may further elucidate what domain of depression may affect the 
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CVD p-value for 
difference N=1,062 N=1,388 
Age, mean(SD) 70.5 (4.0) 72.1 (4.8) <0.01 
White, n(%) 936 (88.1) 1,220 (87.9) 0.86 
Hispanic, n(%) 9 (0.9) 14 (1.0) 0.27 
Male, n(%) 345 (32.5) 575 (41.4) <0.01 
High School Graduate, n(%) 867 (81.6) 1,050 (75.7) <0.01 
Married, n(%) 745 (70.2) 947 (68.2) 0.31 
mCES-D Score, mean (SD) 3.9 (3.9) 4.2 (4.1) 0.06 
Poverty, n(%) 168 (15.8) 288 (20.8) <0.01 
ApoE ε4, n(%) 243 (22.9) 285 (20.5) 0.22 
Diabetes, n(%) 49 (4.6) 118 (8.5) <0.01 
Current Smokers, n(%) 88 (8.3) 186 (13.4) <0.01 
Hypertension, n(%) 302 (28.4) 591 (42.6) <0.01 
Antihypertensive Medications n(%) 306 (28.8) 571 (41.1) <0.01 
Antidepressant Medications, n(%) 32 (3.0) 51 (3.7) 0.51 
BMI, mean (SD) 26.2 (4.4) 26.6 (4.3) 0.06 
SBP, mean (SD) 130.7 (18.7) 136.8 (21.8) <0.01 
Total cholesterol, mean (SD) 210.6 (35.6) 213.1 (39.0) 0.10 
HDL cholesterol, mean (SD) 57.9 (16.4) 54.6 (15.2) <0.01 
Time on Study, mean (SD) 8.8 (1.4) 8.5 (1.6) <0.01 
SD=standard deviation, HDL=high density lipoprotein, mCES-D: modified Centers for 




Table 2. Prevalence and onset of MCI/dementia and persistent depressive symptoms among participants without baseline clinical 
cardiovascular disease: Results from Cardiovascular Health Study (N=2,819) 
 
 
  N (%) 
Incident MCI 440 (15.6%) 
Prevalent dementia at baseline 145 (5.1%) 
Not prevalent dementia at baseline 1,883 (66.8%) 
Incident dementia 351 (12.5%) 
Developed neither persistent depressive symptoms nor MCI/dementia 1,677 (65.4%) 
Developed only persistent depressive symptoms 159 (6.2%) 
Developed only MCI/dementia 592 (23.1%) 
Developed MCI/dementia before year 5 138 (5.2%) 
Developed incident dementia before year 5 108 (4.0%) 
Developed both 137 (5.34%) 
Persistent depressive symptoms first before year 5 136 (99.3%) 
MCI/dementia first before year 5 1 (0.7%) 
Co-occurring with MCI/dementia  0 (0.0%) 
Time in years from baseline to persistent depressive symptoms, mean (SD)  2.9 (0.1) 
Time in years from baseline to MCI/dementia, mean (SD) 8.1 (2.2) 
 






Table 3. Decomposition of total effect of subclinical cardiovascular disease and MCI/dementia onset into direct and indirect effects 
via persistent depressive symptoms using Accelerated Failure Time Models with a Weibull distribution 






Total Effect 0.88 (0.83, 0.93) 
Direct Effect 0.95 (0.92, 0.98) 
Indirect Effect (Through Persistent Depressive Symptoms) 0.92 (0.88, 0.97) 
Percent Mediated on the Log TR Scale 64.48% 
  
Bolded means p<0.05 
Note: Time Ratio (TR), TR<1, indicates a decrease in time without MCI/dementia and TR>1 indicates a prolonged time without 







Table 4. Decomposition of total effect of subclinical cardiovascular disease and MCI/dementia onset into direct and indirect effects 
via persistent depressive symptoms using Accelerated Failure Time Models with a Weibull distribution and propensity score matching 
 







Total Effect 0.88 (0.83, 0.93) 
Direct Effect 0.95 (0.92, 0.99) 
Indirect Effect (Through Persistent 
Depressive Symptoms) 0.92 (0.88, 0.97) 
Percent Mediated on the Log TR Scale 65.23% 
 Bolded values mean p<0.05. 
Note: Time Ratio (TR), TR<1, indicates a decrease in time without MCI/dementia and TR>1 indicates a prolonged time without 





Table 5. Decomposition of total effect of subclinical cardiovascular disease and incident dementia into direct and indirect effects via 
persistent depressive symptoms using Accelerated Failure Time Models with a Weibull distribution 
 







Total Effect 0.86 (0.73, 1.04) 
Direct Effect 0.87 (0.79, 0.96) 
Indirect Effect (Through Persistent 
Depressive Symptoms) 0.99 (0.86, 1.16) 
Percent Mediated on the Log TR Scale 6.66% 
 Bolded values mean p<0.05. 
Note: Time Ratio (TR), TR<1, indicates a decrease in time without incident dementia and TR>1 indicates a prolonged time without 
incident dementia. Percent mediated on the log TR scale was calculated by: [ ln(TRindirect effect)/ln(TRtotal effect)]*100. 
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Figure 1. Hypothesized pathway linking cardiovascular disease, depression, Mild 
Cognitive Impairment, and dementia. This figure illustrates persistent depressive 
symptoms partially mediating the association between subclinical cardiovascular disease 










Figure 2. Kaplan-Meier plot for the association of baseline subclinical cardiovascular disease 
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Figure 3. Kaplan-Meier plot for the association of baseline subclinical cardiovascular disease 
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Figure 4. Diagnostic plots to compare two stopping rules (Effect Size [ES] and Kolmogorov-




Note: All Absolute standardized mean difference or Effect Size (es.mean.ATE) and Kolmogorov-Smirnov (ks.mean.ATE) test 
statistic. ES uses the effect size or the absolute standardized bias and summarizes across variables with the mean. KS uses KS 
statistics to assess balances and summarizes using the maximum across the variables.  
 
Spread of the estimated propensity scores in the treatment and comparison groups for two stopping rules by boxplots (Panel A) 







Figure 5. Comparison of histograms of weights for average treatment effect between 
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Introduction:  Presence of vascular damage, represented as subclinical cardiovascular 
disease (CVD), and depression are associated and are each independent risk factors of all-
cause mortality, but the interplay between subclinical CVD and depression leading to all-
cause mortality is unclear. 
 
Methods: Using an analytic sample from the Cardiovascular Health Study (N=3,473) that 
excluded baseline clinical CVD, we implemented Cox Proportional Hazards model to 
examine the direct and indirect (via persistent depressive symptoms) effects of the 
association between subclinical CVD and all-cause mortality with weights derived from 
multivariable logistic regression model of persistent depressive symptoms on subclinical 
CVD. Analyses were adjusted for baseline covariates: age, race, sex, poverty status, 
marital status, educational level, ApoE ε4 status, and depressive symptoms. Two 
consecutive scores ≥8 on the 10-item Center for Epidemiologic Studies-Depression Scale 
defined persistent depressive symptoms. 
 
Results: Participants contributed 55,157.1 person-years with a mean of 15.2 years of 
follow-up. Baseline subclinical CVD led to a higher risk of all-cause mortality (Hazard 
Ratio, [HR]: 1.58, 95% Confidence Interval, [CI]: 1.34, 1.87). Total effect of baseline 
subclinical CVD on all-cause mortality was decomposed into direct (HR=1.45, 95% CI: 
1.34, 1.58) and indirect (HR=1.09, 95% CI: 0.95, 1.25) effects. 18.8% of the total effect 





Conclusions:   Subclinical CVD is a risk factor of all-cause mortality. Persistent 
depressive symptoms accounts for very little, if any, of the association between 
subclinical CVD and all-cause mortality. 
 





 Some of the strongest predictors of mortality are noninvasive, objective measures 
of both subclinical and clinical cardiovascular disease (CVD) (Fried et al., 1998). Kuller 
et al. (1995) developed an index of subclinical CVD, based on ankle-brachial blood 
pressure, carotid artery stenosis and wall thickness, positive responses of the Rose angina 
and claudication questionnaire from participants without clinical evidence of angina or 
claudication. The index of subclinical CVD was a strong predictor of developing clinical 
CVD and all-cause mortality after 10 or more years of follow-up (Kuller et al., 2006). 
 Another predictor of mortality is depressive symptoms (Ariyo et al., 2000; 
Barefoot & Schroll, 1996). Schulz et al. (2000) reported that milder or subthreshold 
forms of depression increase the risk of death in older adults. Behavioral and 
pathopsychological mechanisms may explain the association between depression and 
morality. Older, depressed adults may disengage from healthy behaviors and social 
situations, thus leading to neuroendocrine system dysregulation and compromise of the 
homeostatic immune function (Schulz et al., 2000). 
 CVD and depressive symptoms are associated, but these conditions may have a 
bi-directional relationship. Sheline et al. (2006) reported an association between clinical 
CVD and depression onset, whereas Ariyo et al. (2000) found that depression led to the 
onset of clinical CVD. The vascular depression hypothesis may help elucidate the 
association between CVD and depression (Alexopoulos et al., 1997). Depression may 
underlie the association between CVD and all-cause mortality.  
One study that examined the associations among CVD, depression, and all-cause 
mortality was conducted by Almeida, Alfonso, Flicker, Hankey, and Norman (2012).  
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Using data from the Health in Men Study, Almeida et al. (2012) examined the joint 
effects of CVD and depression on all-cause mortality and concluded that CVD and 
depression did not have any synergistic effects on all-cause mortality. This study did not 
examine whether depression had a mediating role in the association between CVD and 
all-cause mortality. 
The objective of this study is to determine the role in depressive symptoms in the 
association between subclinical cardiovascular disease and all-cause mortality. By 
examining an earlier part of the vascular pathway prior to the development of clinical 
CVD, we may find that subclinical CVD leads to elevated risk of depressive symptoms. 
We hypothesize that depressive symptoms partially mediate the association between 
subclinical CVD and all-cause mortality. To examine this objective, we will use the 







The study was conducted using the Cardiovascular Health Study, a community-
based study of 5,888 men and women aged 65 years and older at baseline. Study design, 
eligibility criteria, and recruitment characteristics are available elsewhere (Fried et al., 
1991). Briefly, participants underwent interview and clinical assessments annually from 
1989 to 1999 and telephone follow-up visits occur to present. Hospital discharge 
summaries and ICD-9 codes for all hospitalizations were collected during the follow-up 
period (Fried et al., 1991).  
We excluded those with baseline cardiovascular disease (N=1,517), those who 
died before Year 5 (N=456), and those with missing persistent depressive symptoms 
(N=442). There were 3,473 participants in this analysis.  
 
Subclinical Cardiovascular Disease 
 
Subclinical CVD was defined as the presence or the absence of subclinical CVD 
at baseline. Subclinical CVD was defined as having any one of the following at baseline:  
ankle-arm index less than or equal to 0.9, internal and common carotid wall thickness 
greater than 80th percentile, carotid stenosis greater than 25%, major ECG abnormalities, 
and Rose questionnaire identifying either claudication positive or angina positive without 
clinical history of angina or claudication (Chaves et al., 2004; Kuller et al., 2006; Kuller 
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et al., 1995). Methods describing the index of subclinical CVD are described elsewhere 
(Kuller et al., 1995).  
 
Persistent Depressive Symptoms 
 
Persistent depressive symptoms were defined as having two consecutive scores of 
8 or more on the modified Center for Epidemiologic Studies-Depression Scale (mCES-D) 
(Carnetheon et al., 2007). The mCES-D is a short self-reported measure of depressive 
symptoms experienced during the previous week (Andresen, Malmgren, Carter, & 
Patrick, 1994). There are questions on mood (5 items), irritability (1 item), calories 
(energy) (2 items), concentration (1 item), and sleep (1 item). Items are coded on a scale 
from 0 (rarely or none of the time) to 3 (most or all of the time), for a maximum of 30 
points. Higher score indicates greater depressive symptoms. Compared to the original 20-
item CES-D, the reliability of the mCES-D (Cronbach α statistic, 0.80) is slightly lower 
(Cronbach α statistic, 0.86), and there is a 0.88 correlation between the 10-item CES-D 




There was 98% complete ascertainment of death status through 2015. Deaths 
were obtained through passive ascertainment of obituaries, medical records, death 
certificates, and the Centers for Medicare and Medicaid Services health care utilization 
database for hospitalizations, and through active ascertainment of contacting households 
96 
 
to follow up on vital status (Schulz et al., 2000). For all deaths, the cause of death was the 
underlying cause, not necessarily the immediate cause (Newman et al., 2009). Cause of 
death was adjudicated by a committee of physicians without knowledge of prior 




Additional baseline covariates included age, race, male sex, poverty status, 
marital status, education level, ApoE ε4, and depressive symptoms.  Race was defined as 
Caucasian vs. non-white. Poverty status was an income cut-off below $11,770 from 
Federal Poverty Level Guidelines (Dickon, 2015). Marital status was coded as married 
vs. unmarried. Education level was defined as high school graduate vs. not. ApoE ε4 was 
categorized as the presence of at least one allele. Depressive symptoms were defined as 




We characterized the sample at the first visit using means and percentages, and 
we evaluated differences among the exposures of each of the three models throughout the 
follow-up period, using t-tests for continuous variables and χ2 tests for categorical 
variables.  
We estimated Kaplan-Meier survival curves to compare cumulative proportions 
of all-cause mortality between those with and without subclinical CVD (Kaplan & Meier, 
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1958). The difference in the cumulative proportions of all-cause mortality between 
presence and absence of baseline subclinical CVD was tested using a log-rank test (Bland 
& Altman, 2004). Time from the first study visit (baseline) was the time-scale used in the 
analysis. Participants contributed time from baseline until death, loss to follow-up, or 
administrative censoring in 2015. 
Figure 1 shows the hypothesized direct and indirect pathways connecting baseline 
subclinical CVD to all-cause mortality via persistent depressive symptoms. Subclinical 
CVD was measured at baseline. Persistent depressive symptoms, the mediators, were 
measured 2-3 years after baseline, and the outcome, all-cause mortality, was ascertained 
at least five years from baseline up to 24 years from baseline. There were two-year lags 
between the exposure and the mediators as well as the mediators and the outcome.  
To decompose the total effect between baseline subclinical CVD and all-cause 
mortality into direct and indirect effects, we used the counterfactual approach for causal 
mediation, as proposed by Lange and Hansen (2011) and VanderWeele (2011). The 
observed variables are exposure A, mediator M, outcome Y, and baseline covariates C. 
The counterfactual variables are Ya,m, which is the outcome we would have observed if 
exposure A had been set to value a and mediator M was set to m, and Ma, value of 
mediator if exposure A was set to a. The nested counterfactual is 𝑌𝑎∗, 𝑀𝑎 , the outcome we 
would have observed if A were set to a* and M to the value it would have taken if A were 
set to a. Model assumptions include (1) no unmeasured confounding of the exposure-
outcome relationship, (2) no unmeasured confounding of the exposure-mediator 
relationship, (3) no unmeasured confounding of the mediator-outcome relationship, and 
(4) no unmeasured confounding of the mediator-outcome relationship after prior 
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exposure (Lange & Hansen, 2011; VanderWeele, 2011). Assumption 3 cannot be tested 
using observational data (Lange & Hansen, 2011). 
To apply the counterfactual framework, we obtained unbiased estimates for direct 
and indirect effects from weighted Cox proportional hazards models with a duplicated 
dataset with two replications of the exposure. This approach is the same one used by 
Rochon, Bois, and Lange (2014). In the first replication, A* is set to the original value of 
the exposure. In the second replication, A* is set to the opposite (or “counterfactual”) 
value of the exposure. Weights are determined by W
c
=P(M|A*, C)/P(M|A, C), with 
proportions being derived from multivariable logistic regression model of persistent 
depressive symptoms, M, on baseline subclinical CVD (A and A*) and baseline 
covariates, C (Rochon et al., 2014). Standard errors and 95% confidence intervals were 
determined by 5,000 bootstrap simulations (Lange & Hansen, 2011).  The analysis with 
weighted Cox Proportional Hazards models was performed in R version 3.1.2 (R: A 
Language and Environment for Statistical Computing, 2013). All other analyses were 




 To examine whether confounding had an effect on both the exposure-mediator 
relationship and exposure-outcome relationship, we used propensity score matching, 
since the exposed and unexposed groups were unequally distributed (Ridgeway, 
McCaffrey, Morral, Burgette, & Griffin, 2014). Propensity scores were based on 
estimates from a multivariable logistic regression using baseline demographic 
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characteristics, (i.e., age, sex, race, poverty status, marital status, education level), ApoE 
ε4 status, and baseline depressive symptoms and assigned to participants. We performed 
diagnostic checks to assess the adequacy of matching (Ho, Imai, King, & Stuart, 2007; 
Ridgeway et al., 2014). We conducted the main statistical analysis with the matched data 
set. To account for small differences in the matched sample, we further adjusted the 






Characteristics of the Study Sample 
 
Table 1 shows baseline characteristics of the study sample stratified by presence 
(N=1,453) and absence (N=2,020) of baseline subclinical CVD. Those with subclinical 
CVD were more likely to be older, Caucasian, male, and impoverished, current smokers 
(all p’s<0.01). Also, they had more depressive symptoms, lower HDL cholesterol, higher 
total cholesterol, higher systolic blood pressure, diabetes, and treated hypertension (all 
p’s<0.01) (Table 1). As compared to those without baseline subclinical CVD, those with 
baseline subclinical CVD were less likely to be high school graduates and married, and 
they had less time on study (all p’s<0.01). Those with and without baseline subclinical 
CVD were similar in terms of ethnicity, baseline depressive symptoms, ApoE ε4 status, 
antidepressant medications, and body mass index (all p’s>0.05) (Table 1). 
Table 2 shows the frequencies and percentages of the overall sample restricted to 
those without baseline clinical CVD. There were 456 (10.4%) who died within five years 
of baseline. About 17.6% (N=641) developed neither persistent depressive symptoms nor 
all-cause mortality, whereas 2.0% (N=74) developed only persistent depressive 
symptoms, 17.7% (N=352) died without persistent depressive symptoms, and 11.1% 
(N=406) died with persistent depressive symptoms (Table 2). Of those who died with 
persistent depressive symptoms, persistent depressive symptoms were present first prior 
to year 5 (100%) (Table 2).  
101 
 
Figure 2 shows Kaplan-Meier survival curves comparing the risk of all-cause 
mortality between those with and without baseline subclinical CVD. The cumulative 
proportion of all-cause mortality is higher among those with baseline subclinical CVD 
than those without baseline subclinical CVD (p<0.01). Participants contributed 55,157.06 
person-years with a mean of 15.2 years (median of 15.9 years) between baseline and all-
cause mortality, loss to follow-up, and end of follow-up in 2015.  
 
Indirect Effect of Persistent Depressive Symptoms on the Association of Subclinical CVD 
with All-Cause Mortality 
 
The total effect of subclinical CVD on all-cause mortality and its decomposition 
into natural indirect and direct effects is shown in Table 3. The total HR for the 
association between subclinical CVD and all-cause mortality was 1.58 (95% CI: 1.34, 
1.87) (Table 3). The total HR was decomposed into a direct HR of subclinical CVD of 
1.45 (95% CI: 1.34, 1.58) and indirect HR for persistent depressive symptoms of 1.09 
(95% CI: 0.95, 1.25) (Table 3). Persistent depressive symptoms account for 18.8% for the 




To assess several assumptions of the counterfactual approach for causal 
mediation, we used propensity score matching. Figures 3 and 4 are the diagnostic plots 
for the propensity score matching. When we conducted the same analysis in a matched 
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sample and further adjusted the analysis by baseline covariates, we found that those with 
baseline subclinical CVD had 1.41 (95% CI: 1.30, 1.52) times the risk of all-cause 
mortality than those without baseline subclinical CVD (Table 4). When the total effect 
was decomposed into the direct and indirect effect, the direct effect (HR=1.41, 95% CI: 
1.30, 1.52) explained 100% of the total effect between subclinical CVD and all-cause 
mortality. There was no indirect effect of persistent depressive symptoms (HR=1.00, 95% 




 Those with subclinical CVD were at an elevated risk of all-cause mortality, 
compared to those without subclinical CVD. Most of the total effect was explained by the 
direct effect of subclinical CVD on all-cause mortality. Persistent depressive symptoms 
explained 18.8% of the total effect of subclinical CVD on risk of all-cause mortality. 
When sensitivity analysis was conducted to further adjust for any potential confounding 
by propensity score matching, persistent depressive symptoms did not account for any of 
the total effect of subclinical CVD on all-cause mortality. These findings suggest that 
subclinical CVD is a risk factor of all-cause mortality and persistent depressive 
symptoms do not lie on that pathway.   
The results are consistent with those from Almeida et al. (2012). They reported 
that depression and CVD were independently associated with all-cause mortality and that 
depression did not modify the association between CVD and all-cause mortality. Other 
studies have found that depression and subclinical CVD are independently associated 
with all-cause mortality, although these studies did not examine mediation of depression 
on the association between subclinical CVD and all-cause mortality (Ariyo et al., 2000; 
Kuller et al., 1995; Schulz et al., 2000).  
One potential explanation for these results could be that the prevalence of 
depression remains stable until it declines during the 7th decade of life (Kessler et al., 
2003) while the prevalence of clinical CVD, such as coronary heart disease, stroke, and 
atherosclerosis, increase exponentially with greater age (Bakhai, 2004). If vascular 
disease were related to late-onset depression, one would expect the prevalence of 
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depression to increase exponentially with greater age as well, but this trend is not 
observed (de Leeuw et al., 2001; Newson et al., 2010). 
There are several strengths of this study.  First, there is a large sample of older 
adults with repeated measures on depressive symptoms and all-cause mortality over a 
period of up to 24 years. Second, all-cause mortality is an outcome with over 98% 
ascertainment through the end of the study period we used, so we were able to measure 
the outcome without any missingness. Third, all causes of death were adjudicated by a 
committee of physicians. Fourth, investigators from the CHS developed an index of 
subclinical CVD based on objective measures (Kuller et al, 1995).  
Despite the strengths of the study, there were several limitations. One limitation is 
the lack of clinical diagnosis of depression in CHS. However, the mCES-D may measure 
depressive symptoms in older adults who would not meet diagnostic criteria for 
depressive disorder. About 13% of the sample had persistent depressive symptoms 2-3 
years after baseline, which is similar to the prevalence of depressive symptoms among 
community-dwelling older adults reported by Blazer (2003). Another limitation is the 
inability to test the assumption of unconfoundedness in observational studies, since the 
exposure was not randomized in the study sample. We limited the influence of 
confounding on the exposure-mediator and exposure-outcome relationships through 
propensity score matching, though. When we used the matched dataset, there was no 
evidence of an indirect effect of persistent depressive symptoms on the association 
between subclinical CVD and all-cause mortality. 
To address concerns about confounding in the exposure-mediator and exposure-
outcome associations, we adjusted the analysis by baseline covariates that were related to 
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exposure, mediator, and outcome. We introduced two-year lags to examine relative 
ordering of baseline subclinical CVD, persistent depressive symptoms measured 2-3 
years after baseline, and all-cause mortality ascertained from at least five years after 
baseline. We conducted a sensitivity analysis with propensity scores based on baseline 
covariates to determine whether inferences remained.  
Although baseline subclinical CVD had a positive effect on all-cause mortality, 
persistent depressive symptoms did not mediate the association between subclinical CVD 
and all-cause mortality. Persistent depressive symptoms and subclinical CVD both lead to 
all-cause mortality, but these conditions are independent of one another. The vascular 
pathway may be strongly correlated with all-cause mortality in older adults, such that 
depression does not have an effect on the association between subclinical CVD and all-
cause-mortality.  
There are a couple of future directions that may elucidate whether persistent 
depressive symptoms indirectly affect the association between subclinical CVD and all-
cause mortality. The first would be to examine the indirect effect of each domain of the 
mCES-D on the association between subclinical CVD and all-cause mortality. A 
particular domain of the mCES-D may inform whether specific domains of depression, 
i.e., positive affect, depressed affect, somatic complaints, and interpersonal conflicts, may 
affect the association between subclinical CVD and all-cause mortality. Another direction 
would be to examine vascular processes in mid-life instead of late life. Late-onset 
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CVD p-value for 
difference N=1,453 N=2,020 
Age, mean(SD) 70.8 (4.4) 72.7 (5.2) <0.01 
White, n(%) 1,273 (87.6) 1,718 (85.1) 0.03 
Hispanic, n(%) 18 (1.2) 21 (1.0) 0.86 
Male, n(%) 467 (32.1) 805 (39.9) <0.01 
High School Graduate, n(%) 1,163 (80.0) 1,460 (72.3) <0.01 
Married, n(%) 1,018 (70.1) 1,337 (66.2) 0.02 
mCES-D Score, mean (SD) 4.1 (4.1) 4.3 (4.2) 0.15 
Poverty, n(%) 252 (17.3) 473 (23.4) <0.01 
ApoE ε4, n(%) 337 (23.2) 425 (21.0) 0.21 
Diabetes, n(%) 78 (5.4) 188 (9.3) <0.01 
Current Smokers, n(%) 118 (8.1) 267 (13.2) <0.01 
Hypertension, n(%) 439 (30.2) 879 (43.5) <0.01 
Antihypertensive Medications n(%) 460 (31.7) 845 (41.8) <0.01 
Antidepressant Medications, n(%) 52 (3.6) 70 (3.5) 0.97 
BMI, mean (SD) 26.4 (4.7) 26.7 (4.5) 0.06 
SBP, mean (SD) 131.7 (19.1) 138.2 (22.0) <0.01 
Total cholesterol, mean (SD) 211.0 (36.1) 213.8 (39.9) 0.03 
HDL cholesterol, mean (SD) 57.8 (16.1) 54.6 (15.5) <0.01 
Time on Study, mean (SD) 17.4 (5.4) 14.8 (5.6) <0.01 
SD=standard deviation, HDL=high density lipoprotein, mCES-D: modified Centers for 









Table 2. All-cause mortality and persistent depressive symptoms among participants without baseline clinical cardiovascular disease: 
Results from Cardiovascular Health Study (N=4,371) 
 
  N (%) 
Death within five years of baseline 456 (10.4%) 
Developed neither persistent depressive symptoms nor all-cause mortality 641 (17.6%) 
Developed only persistent depressive symptoms 74 (2.0%) 
Developed only all-cause mortality 352 (17.7%) 
Developed both 406 (11.1%) 
Persistent depressive symptoms first before year 5 406 (100.0%) 
All-cause mortality first before year 5 0 (0.0%) 
Co-occurring with all-cause mortality  0 (0.0%) 
Time in years from baseline to persistent depressive symptoms, mean (SD)  2.9 (0.1) 
Time in years from baseline to all-cause mortality, mean (SD) 14.3 (6.6) 
 
 







Table 3. Causal mediation analysis using survival data: total, direct, and indirect effects 
from weighted continuous-time Cox Proportional Hazards Models of the association 
between subclinical cardiovascular disease and all-cause mortality via persistent 
depressive symptoms. Model was adjusted by race, sex, education level, marital status, 
age, ApoE ε4, depressive symptoms, and poverty status at baseline.    
 
 






Total Effect 1.58 (1.34, 1.87) 
Direct Effect 1.45 (1.34, 1.58) 
Indirect Effect (Through Mediator) 1.09 (0.95, 1.25) 
Percent Mediated on Log HR Scale 18.84%   
 
HR=hazards ratios, CI=confidence intervals. Bolded values indicate that result was 
statistically significant at p<0.05. 
NOTE: Percent mediated on the log HR scale was calculated as [ln(HRindirect 
effect)/ln(HRtotal effect)]*100.   
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Table 4. Sensitivity analysis with propensity scores - causal mediation analysis using 
survival data: total, direct, and indirect effects from weighted continuous-time Cox 
Proportional Hazards Models of the association between subclinical cardiovascular 
disease and all-cause mortality via persistent depressive symptoms. Model was adjusted 
by race, sex, education level, marital status, age, ApoE ε4 status, depressive symptoms, 
and poverty status at baseline.    
 
 






Total Effect 1.41 (1.30, 1.52) 
Direct Effect 1.41 (1.30, 1.52) 
Indirect Effect (Through Mediator) 1.00 (1.00, 1.00) 
Percent Mediated 0.00%   
 
 
HR=hazards ratios, CI=confidence intervals. Bolded values indicate that result was 
statistically significant at p<0.05. 
NOTE: Percent mediated on the log HR scale was calculated as [ln(HRindirect 
effect)/ln(HRtotal effect)]*100.  
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Figure 1. Hypothesized pathway linking subclinical cardiovascular disease, persistent 
depressive symptoms, and all-cause mortality.  This figure illustrates persistent 
depressive symptoms partially mediating the association between subclinical 






Figure 2. Kaplan-Meier plot of the association of baseline subclinical cardiovascular 
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Figure 3. Diagnostic plots to compare two stopping rules (Effect Size [ES] and 






Note: All Absolute standardized mean difference or Effect Size (es.mean.ATE) and Kolmogorov-Smirnov 
(ks.mean.ATE) test statistic. ES uses the effect size or the absolute standardized bias and summarizes across variables 
with the mean. KS uses KS statistics to assess balances and summarizes using the maximum across the variables. 
  
Spread of the estimated propensity scores in the treatment and comparison groups for two stopping rules by boxplots 







Figure 4. Histograms for weights of propensity scores for the average treatment effect by 



























Public health implications 
 
 Depression, although common in older adults, is undertreated. As the global 
population continues to age, treatment of depression will become a growing problem. 
Cardiovascular disease is already a common disease, and the top leading cause of death 
in the United States. Dementia is also one of the leading causes of death in the United 
States (James et al., 2014). These three diseases, depression, cardiovascular disease, and 
dementia, are associated with one another among older adults, but the way in which they 
are related is not clear. This study elucidated these relationships.   
 One plausible pathway in which cardiovascular disease, depression, and dementia 
are associated is proposed by the vascular depression hypothesis. Those with 
cardiovascular disease and dementia may have an underlying mood disorder, but the 
timing of these associations is unclear. Cardiovascular disease and depression could co-
occur with one another, leading to an increased risk of developing dementia and 
subsequent death. Depression could lead to cardiovascular disease, or vice versa. In this 
study, we evaluated subclinical cardiovascular disease occurring prior to persistent 
depressive symptoms to determine whether persistent depressive symptoms partially 
mediated the association of subclinical cardiovascular disease with onset of mild 
cognitive impairment, dementia, and death.  
 This study provided insights regarding the role of depression in vascular 
pathways, changes in cognitive function, and mortality. Since depression is undertreated 
in older adults (Crystal, Sambamoorthi, Walkup, & Akincigil, 2003; García-Peña et al., 
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2013; Newberg, Davydow, & Lee, 2006; Wittayanukorn, Qian, & Hansen, 2014), 
positive findings from this study would underscore the need for timely screening and 
treatment of depression among those with vascular risk factors to reduce risk of 
morbidity and decline in physical functioning as well as the burden on the utilization of 
health services (Crystal et al., 2003; Wittayanukorn et al., 2014). 
 
Review of Specific Aim 1  
 
 In Specific Aim 1, we examined the effect of the timing of cardiovascular risk 
factors and vascular burden before and after age 65 on onset of incident depression 
among men, using data from the Johns Hopkins Precursors Study. We found that vascular 
burden after age 65, diabetes before and after age 65, hypertension before age 65, and 
hyperlipidemia before age 65 have strong associations with subsequent incident 
depression after age 65. We did not find associations between cardiovascular risk factors 
and onset of incident depression before age 65 with the exception of overweight/obese 
having a protective effect against incident depression before age 65. To account for the 
competing risk of death, we used Long-Gray method to examine subhazard ratios of 
associations of cardiovascular risk factors and onset of death before incident depression 
(Fine & Gray, 1999). Diabetes and ever smoking status were associated more with death 
than depression after age 65.   
 




 In Specific Aim 2, we evaluated the indirect effect of persistent depressive 
symptoms on the association of subclinical cardiovascular disease with onset of mild 
cognitive impairment and dementia, using data from the Cardiovascular Health Study. 
We found that persistent depressive symptoms partially mediated the association of 
subclinical cardiovascular disease with onset of mild cognitive impairment and dementia 
in older adults. This result still held when we matched the sample by propensity scores. 
Additionally, we evaluated the indirect effect of persistent depressive symptoms on the 
association between subclinical cardiovascular disease and dementia. There was no 
indirect effect of persistent depressive symptoms on the association between subclinical 
cardiovascular disease and incident dementia. However, those with baseline subclinical 
cardiovascular disease had an elevated risk of onset of incident dementia, compared to 
those without baseline subclinical cardiovascular disease.    
 
Review of Specific Aim 3  
 
In Specific Aim 3, we evaluated the mediating role of persistent depressive 
symptoms on the association between subclinical cardiovascular disease and all-cause 
mortality, using data from the Cardiovascular Health Study. We found that there was no 
indirect effect of persistent depressive symptoms on the association between subclinical 
cardiovascular disease and all-cause mortality in older adults. This finding suggests that 
subclinical cardiovascular disease and persistent depressive symptoms lie on independent 




Study limitations  
 
 One important limitation is that the two cohort studies differed in terms of 
measurement of key constructs and timing thereof. The Johns Hopkins Precursors Study 
is a longitudinal observation study consisting of former medical students with 
approximately annual measures since early adulthood. Vascular burden was measured by 
a modified version of the Framingham Cardiovascular Disease Risk Score in the Johns 
Hopkins Precursors Study, and subclinical cardiovascular disease and mild cognitive 
impairment were not measured in the Johns Hopkins Precursors Study. The measures of 
depressive symptoms were limited to 2005 and 2007. First, we could not use consecutive 
scores from a two-year period, since depressive symptoms were collected in 2005 and 
2007. If we used both scores from 2005 and 2007, then we would only be able to evaluate 
the outcome, starting in 2009. The end of the analytic period was 2011, thus allowing two 
years of assessment of the outcome.  
While the Johns Hopkins Precursors Study has measures collected from early and 
middle adulthood, the Cardiovascular Health Study is limited to data collected on 5,888 
men and women recruited from Medicare eligibility lists in later life. Midlife 
cardiovascular risk factors cannot be examined within this cohort. The Cardiovascular 
Health Study also lacks diagnosis of clinical depression, but has measures of depressive 
symptoms and neuropsychological tests approximately annually over an 18-year period.  
 




Incidences of depression in our study are not comparable to nationally 
representative estimates because we excluded cases occurring before graduation, leading 
to lower incidence before age 65 than national estimates (Kessler & Wang, 2008). 
Additionally, physicians have higher rates of depression than the general population, thus 
the overall incidence rate in our sample of 22.3% is slightly higher than national 
estimates of 16.6% (Kessler & Wang, 2008).  
Another caveat is other variables not incorporated into the analyses, i.e., genes 
and anxiety, could bias associations. Selection factors could also affect our study’s 
generalizability; particularly, high socioeconomic status could have a protective effect 
against depression, thus leading to a potentially conservative estimate of risk related to 
depression (Ford et al., 1998). This limitation is also an advantage because the sample’s 
homogeneity and selectivity ensures fewer unknown confounders. A third limitation is 
the small sample size and limited number of cases especially in the under-65 analysis, 
resulting in wide confidence intervals. Fourth, some participants (11%) died before age 
65, thus death is a potentially competing outcome with depression after age 65 although 
sensitivity analyses showed no cardiovascular risk factors are associated with death prior 
to depression before age 65.   
 
Limitations specific to Specific Aim 2 
 
First, a main assumption of the mediation analysis is that all relevant confounders 
are included in the analysis. We included baseline demographic characteristics, baseline 
depressive symptoms, and ApoE ε4 as potential confounders in this analysis for 
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predictor, mediator, and outcome. Also, we conducted sensitivity analyses to determine if 
we still saw a similar result from the main analysis when the outcome was incident 
dementia. We also conducted the same analysis in a matched dataset based on propensity 
scores, and there was no change in inferences from the main analysis. Another limitation 
is the requirement of no other variables that confound the mediator-outcome association, 
but this is untestable in observational studies (Lange & Hansen, 2011). The third 
limitation is that an external replication analysis could not be performed, since there were 
very few cases of dementia in the Johns Hopkins Precursors Study.  
 
Limitations specific to Specific Aim 3 
 
One limitation is not having data on subclinical cardiovascular disease in mid-life. 
About one-fifth of the overall sample had prevalent cardiovascular disease at baseline, so 
they were excluded from the sample. If we could have ascertained subclinical 
cardiovascular disease prior to the development of cardiovascular disease, we may have 
had increased power to detect the indirect effect of persistent depressive symptoms on the 
association between subclinical cardiovascular disease and all-cause mortality. However, 
we found that those with baseline subclinical cardiovascular disease had an increased risk 
of all-cause mortality than those without baseline subclinical cardiovascular disease.  The 
second limitation was the inability to replicate the analysis using an external cohort, the 
Johns Hopkins Precursors Study. There were 33 deaths with only three with depressive 
symptoms in 2005. Other limitations were the measurement of all relevant confounders in 
the causal mediation and no confounders in the mediator-outcome relationship. We 
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included baseline demographic characteristics, baseline depressive symptoms, and ApoE 
ε4, since these were associated with subclinical cardiovascular disease, persistent 
depressive symptoms, and all-cause mortality. As for confounders in the mediator-




This current research has many strengths. Both cohort studies allowed for the 
evaluation of cardiovascular conditions, depressive symptoms, and outcomes, such as 
mild cognitive impairment, dementia and all-cause mortality, with at least 18 years of 
follow-up. The CHS has a large heterogeneous sample with measures on cardiovascular 
risk factors, neuropsychological tests, depressive symptoms, dementia, and mortality. The 
Johns Hopkins Precursors Study has repeated measures with up to 53 years of follow-up 
on former medical students for Aim 1. Measures have been validated in the sample, and 
diagnoses have been adjudicated by an independent committee of clinicians.  
Strengths of the Johns Hopkins Precursors Study include available data over a 
long follow-up period and high response rates over the study, data on the diagnosis of 
clinical depression, and valid self-report measures on cardiovascular risk factors. In 
addition to the Johns Hopkins Precursors Study, the strengths of the CHS include a 
geographically diverse sample of community-dwelling older adults aged 65+ years in the 
United States with a long follow-up period (up to 18 years) and approximately annual 
assessments of depressive symptoms and biomarkers of cardiovascular function (Chaves 
et al., 2004; Kuller et al., 2006).  Moreover, both the Johns Precursors Study and the CHS 
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have a high percentage of ascertainment on all-cause mortality, and both studies have 
expert committees that use standardized criteria for evaluating the onset of outcomes 
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Appendix 1: Conceptual Framework 
Figure 1. Conceptual Framework for Study 
 
Our specific aims are focused on the longitudinal analysis of cardiovascular risk factors, 
subclinical cardiovascular disease, depression/depressive symptoms, mild cognitive 
impairment, dementia, and mortality to determine whether the vascular depression 
hypothesis can be extended to include dementia and mortality.  Figure 1 addresses the 
conceptual framework on the proposed project.  First, we assess the temporal associations 
between vascular risk factors and late-life depression (Aim 1).  Second, we will examine 
the indirect effect of persistent depressive symptoms on the association of subclinical 
cardiovascular disease with onset of mild cognitive impairment and dementia (Aim 2).  
Then, we will assess the indirect effect of persistent depressive symptoms on the 
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